<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD004825.pub2" GROUP_ID="PROSTATE" ID="461803112013530291" MERGED_FROM="" MODIFIED="2008-05-27 08:38:44 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.3.1&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.10&lt;br&gt;Exported from Review Manager 4.3.1&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.3.1&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.3&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.3&lt;/p&gt;&lt;p&gt;Old title: Psychosocial interventions for erectile dysfunction - EXEMPLO IN&amp;#205;CIO DA AN&amp;#193;LISE&lt;br&gt;Old title: Psychosocial interventions for erectile dysfunction&lt;/p&gt;" NOTES_MODIFIED="2008-05-27 08:38:44 -0500" NOTES_MODIFIED_BY="[Empty name]" REVIEW_NO="13" REVMAN_SUB_VERSION="5.0.10" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="5.0">
<COVER_SHEET MODIFIED="2008-05-27 08:38:44 -0500" MODIFIED_BY="[Empty name]">
<TITLE>Psychosocial interventions for erectile dysfunction</TITLE>
<CONTACT>
<PERSON ID="E356C47D82E26AA201E74FE958EC3CF0" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Tamara</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Melnik</LAST_NAME>
<SUFFIX>PhD</SUFFIX>
<POSITION>Professor</POSITION>
<EMAIL_1>tameln@terra.com.br</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Psychiatry, Neuroscience and Behavior</DEPARTMENT>
<ORGANISATION>Universidade de São Paulo</ORGANISATION>
<ADDRESS_1>Rua Prof José de Andrade Figueira 540/ 121 Morumbi</ADDRESS_1>
<ADDRESS_2/>
<CITY>São Paulo</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<PHONE_1>+55 11 9182 6531</PHONE_1>
<PHONE_2>+55 11 3507 0417</PHONE_2>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2008-05-27 08:38:44 -0500" MODIFIED_BY="[Empty name]">
<PERSON ID="E356C47D82E26AA201E74FE958EC3CF0" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Tamara</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Melnik</LAST_NAME>
<SUFFIX>PhD</SUFFIX>
<POSITION>Professor</POSITION>
<EMAIL_1>tameln@terra.com.br</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Psychiatry, Neuroscience and Behavior</DEPARTMENT>
<ORGANISATION>Universidade de São Paulo</ORGANISATION>
<ADDRESS_1>Rua Prof José de Andrade Figueira 540/ 121 Morumbi</ADDRESS_1>
<ADDRESS_2/>
<CITY>São Paulo</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<PHONE_1>+55 11 9182 6531</PHONE_1>
<PHONE_2>+55 11 3507 0417</PHONE_2>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="9639" MODIFIED="2008-05-27 08:38:44 -0500" MODIFIED_BY="[Empty name]" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Bernardo</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Soares</LAST_NAME>
<SUFFIX/>
<POSITION>Honorary Fellow</POSITION>
<EMAIL_1>bgos@terra.com.br</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>Brazilian Cochrane Centre</ORGANISATION>
<ADDRESS_1>Rua Pedro de Toledo 598</ADDRESS_1>
<ADDRESS_2>Vila Clementino</ADDRESS_2>
<CITY>São Paulo</CITY>
<ZIP>04039-001</ZIP>
<REGION>SP</REGION>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<PHONE_1>+55 11 5575 2970</PHONE_1>
<PHONE_2/>
<FAX_1>+55 11 5579 0469</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="B3C08E9D82E26AA2007D5B6ECA6E77D1" MODIFIED="2008-05-27 08:38:44 -0500" MODIFIED_BY="[Empty name]" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Antônia</FIRST_NAME>
<MIDDLE_INITIALS>Gladys</MIDDLE_INITIALS>
<LAST_NAME>Nasello</LAST_NAME>
<SUFFIX/>
<POSITION>Professor</POSITION>
<EMAIL_1>gnasiek@amcham.com.br</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Fisiologia</DEPARTMENT>
<ORGANISATION>Faculdade de Medicina da Santa Casa de Misericóridia</ORGANISATION>
<ADDRESS_1>Praça Germania, 15---Apt 131--Jd Paulistano</ADDRESS_1>
<ADDRESS_2/>
<CITY>São Paulo</CITY>
<ZIP>01455-080</ZIP>
<REGION/>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<PHONE_1>55-11-38120771</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2008-03-24 09:10:12 -0500" MODIFIED_BY="Jim Tacklind" NOTES="&lt;p&gt;Minor update: 4/3/07&lt;/p&gt;" NOTES_MODIFIED="2008-03-24 09:10:12 -0500" NOTES_MODIFIED_BY="Jim Tacklind">
<UP_TO_DATE>
<DATE DAY="30" MONTH="3" YEAR="2007"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="30" MONTH="3" YEAR="2007"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="" MONTH="" YEAR=""/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2004"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2007"/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2007"/>
</DATES>
<WHATS_NEW>
<WHATS_NEW_ENTRY EVENT="AMENDMENT">
<DATE DAY="24" MONTH="3" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="30" MONTH="3" YEAR="2007"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>Brazilian Cochrane Center</NAME>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-03-24 13:28:20 -0500" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2008-03-24 13:24:43 -0500" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-03-24 13:24:43 -0500" MODIFIED_BY="[Empty name]">Psychosocial interventions for erectile dysfunction</TITLE>
<SUMMARY_BODY>
<P>Authors conducted a meta-analysis to evaluate the effectiveness of psychological interventions for the treatment of erectile dysfunction (ED) compared to oral drugs, local injection, vacuum devices, or other psychological interventions. Distinct sources of randomised clinical trials (RCTs) were searched, such as electronic databases (between 1966 and 2007). We also crosschecked references and contacted scientific societies. Eleven trials involving 398 men met the inclusion criteria. Conclusions: there is evidence that group therapy (GT) improves ED in selected patients. Focused sex GT showed greater efficacy than control group. Men who received GT plus sildenafil showed significant improvement of ED and were less likely than those receiving only sildenafil to drop out. In comparing the effectiveness of psychological interventions for the treatment of ED versus local injection and vacuum devices, no difference was found.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND>
<P>Normal sexual function is a biopsychosocial process and relies on the coordination of psychological, endocrine, vascular, and neurological factors. Recent data show that psychological factors are involved in a substantial number of cases of erectile dysfunction (ED) alone or in combination with organic causes. However, in contrast to the advances in somatic research of erectile dysfunction, scientific literature shows contradictory reports on the results of psychotherapy for the treatment of ED.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To evaluate the effectiveness of psychosocial interventions for the treatment of ED compared to oral drugs, local injection, vacuum devices and other psychosocial interventions, that may include any psycho-educative methods and psychotherapy, or both, of any kind.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P>The following databases were searched to identify randomised or quasi-randomised controlled trials: MEDLINE (1966 to 2007), EMBASE (1980 to 2007), psycINFO (1974 to 2007), LILACS (1980 to 2007), DISSERTATION ABSTRACTS (2007) and the Cochrane Central Register of Controlled Trials (CENTRAL) (2007). Besides this electronic search cross checking the references of all identified trials, contact with the first author of all included trials was performed in order to obtain data on other published or unpublished trials. Handsearch of the International Journal of Impotence Research and Journal of Sex and Marital Therapy since its first issue and contact with scientific societies for ED completed the search strategy.<BR/>
</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>All relevant randomised and quasi-randomised controlled trials evaluating psychosocial interventions for ED.<BR/>
</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Authors of the review independently selected trials found with the search strategy, extracted data, assessed trial quality, and analysed results. For categorical outcomes the pooled relative risks (RR) were calculated, and for continuous outcomes mean differences between interventions were calculated as well. Statistical heterogeneity was addressed.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>Nine randomised (Banner 2000; Baum 2000; Goldman 1990; Kilmann 1987; Kockott 1975; Melnik 2005; Munjack 1984; Price 1981; Wylie 2003) and two quasi-randomised trials (Ansari 1976; Van Der Windt 2002), involving 398 men with ED (141 in psychotherapy group, 109 received medication, 68 psychotherapy plus medication, 20 vacuum devices and 59 control group) met the inclusion criteria. In data pooled from five randomised trials (Kockott 1975; Ansari 1976; Price 1981; Munjack 1984; Kilmann 1987), group psychotherapy was more likely than the control group (waiting list - a group of participants who did not receive any active intervention) to reduce the number of men with "persistence of erectile dysfunction" at post-treatment (RR 0.40, 95% CI 0.17 to 0.98, N = 100; NNT 1.61, 95% CI 0.97 to 4.76).<BR/>
<BR/>At six months follow up there was continued maintenance of reduction of men with "persistence of ED" in favour of group psychotherapy (RR 0.43, 95% CI 0.26 to 0.72, N = 37; NNT 1.58, 95% CI 1.17 to 2.43).</P>
<P>In data pooled from two randomised trials (Price 1981; Kilmann 1987), sex-group psychotherapy reduced the number of men with "persistence of erectile dysfunction" in post-treatment (RR 0.13, 95% CI 0.04 to 0.43, N = 37), with a 95% response rate for sex therapy and 0% for the control group (waiting list - no treatment) (NNT 1.07, 95% CI 0.86 to 1.44).</P>
<P>Treatment response appeared to vary between patient subgroups, although there was no significant difference in improvement in erectile function according to mean group age, type of relationship, and severity of ED. In two trials (Melnik 2005; Banner 2000) that compared group therapy plus sildenafil citrate versus sildenafil, men randomised to receive group therapy plus sildenafil showed significant reduction of "persistence of ED" (RR 0.46, 95% CI 0.24 to 0.88; NNT 3.57, 95% CI 2 to 16.7, N = 71), and were less likely than those receiving only sildenafil to drop out (RR 0.29, 95% CI 0.09 to 0.93).</P>
<P>One small trial (Melnik 2005) directly compared group therapy and sildenafil citrate. It found a significant difference favouring group therapy versus sildenafil in the mean difference of the IIEF (WMD -12.40, 95% CI -20.81 to -3.99, N = 20).</P>
<P>No differences in effectiveness were found between psychosocial interventions versus local injection and vacuum devices.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>There was evidence that group psychotherapy may improve erectile function. Treatment response varied between patient subgroups, but focused sex-group therapy showed greater efficacy than control group (no treatment). In a meta-analysis that compared group therapy plus sildenafil citrate versus sildenafil, men randomised to receive group therapy plus sildenafil showed significant improvement of successful intercourse, and were less likely than those receiving only sildenafil to drop out. Group psychotherapy also significantly improved ED compared to sildenafil citrate alone. Regarding the effectiveness of psychosocial interventions for the treatment of ED compared to local injection, vacuum devices and other psychosocial techniques, no differences were found.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-03-24 13:28:20 -0500" MODIFIED_BY="[Empty name]">
<BACKGROUND>
<P>The field of erectile dysfunction treatment has expanded rapidly with the advent of oral drug therapy (<LINK REF="REF-Althof-2000" TYPE="REFERENCE">Althof 2000</LINK>; <LINK REF="REF-Althof-2002" TYPE="REFERENCE">Althof 2002</LINK>). Normal sexual function is a biopsychosocial process and relies on the coordination of psychological, endocrine, vascular, and neurological factors (<LINK REF="REF-Levine-2000" TYPE="REFERENCE">Levine 2000</LINK>). Recent data suggests psychological factors are involved either alone or in combination with organic causes in a substantial number of cases (<LINK REF="REF-Ackerman-1995" TYPE="REFERENCE">Ackerman 1995</LINK>; <LINK REF="REF-Althof-2002" TYPE="REFERENCE">Althof 2002</LINK>; <LINK REF="REF-Rosen-2001" TYPE="REFERENCE">Rosen 2001</LINK>).</P>
<P>
<LINK REF="REF-Aydin-2001" TYPE="REFERENCE">Aydin 2001</LINK> studied 115 men with ED and found an organic etiology in 43%, psychogenic in 43% and mixed in 19%. <LINK REF="REF-Melman-1988" TYPE="REFERENCE">Melman 1988</LINK> studied 406 with ED and find 117 (28.8%) with organic ED,161 (39.7%) with psychogenic ED,102 (25.1%) mixed ED and 26 (6.4%) dysfunction of unknown the origin.</P>
<P>Psychogenic ED is defined as persistent inability to achieve and maintain an erection satisfactorily for sexual performance owing predominantly or exclusively to psychological or interpersonal factors (<LINK REF="REF-Rosen-2001" TYPE="REFERENCE">Rosen 2001</LINK>). The main causes of psychogenic ED can be divided into three groups, each one corresponding to a different time phase: 1) immediate factors (performance anxiety); 2) prior recent life events; and 3) developmental vulnerabilities from childhood and adolescence (<LINK REF="REF-Althof-1989" TYPE="REFERENCE">Althof 1989</LINK>).</P>
<P>Epidemiologic studies have implicated the role of depressed mood, loss of self-esteem, anxiety, and other psychosocial stresses in the cause of ED (<LINK REF="REF-Rosen-2001" TYPE="REFERENCE">Rosen 2001</LINK>; <LINK REF="REF-Seidman-2001" TYPE="REFERENCE">Seidman 2001</LINK>; <LINK REF="REF-Feldman-1994" TYPE="REFERENCE">Feldman 1994</LINK>). </P>
<P>The results of psychotherapy in the treatment of ED, in contrast to the advances of pharmacologic interventions, is contradictory in the scientific literature (<LINK REF="REF-Rosen-2001" TYPE="REFERENCE">Rosen 2001</LINK>; <LINK REF="REF-Althof-1989" TYPE="REFERENCE">Althof 1989</LINK>). Few studies have evaluated the benefits of combining drugs and psychotherapy or comparing different psychological approaches (<LINK REF="REF-Rosen-2001" TYPE="REFERENCE">Rosen 2001</LINK>; <LINK REF="REF-Althof-2002" TYPE="REFERENCE">Althof 2002</LINK>; <LINK REF="REF-Perelman-2001" TYPE="REFERENCE">Perelman 2001</LINK>).<BR/>
<BR/>Oral drug therapies, intercavernous injections and vacuum devices are the three treatment modalities that have been most extensively evaluated in controlled studies. As noted by the National Institutes of Heath Consensus Conference of Erectile Dysfunction (<LINK REF="REF-NIH-1992" TYPE="REFERENCE">NIH 1992</LINK>), "outcome data of psychological and behavioral therapy have not been quantified, and the evaluation of success of these treatments is poorly documented". The aim of this review is to evaluate the effectiveness of psychological approaches for the treatment of ED.</P>
</BACKGROUND>
<OBJECTIVES>
<P>Evaluate the efficacy of psychosocial interventions for the treatment of ED compared to oral drugs, local injection, vacuum devices, and other psychological techniques.<BR/>Evaluate the effectiveness of psychosocial interventions for the treatment of ED compared to oral drugs, local injection, vacuum devices, and other psychosocial intervention, and that may include any psycho-educative methods or psychotherapy of any kind.</P>
</OBJECTIVES>
<METHODS>
<SELECTION_CRITERIA>
<CRIT_STUDIES>
<P>All relevant randomised and quasi-randomised controlled trials evaluating psychosocial interventions for erectile dysfunction.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Men with diagnosis of ED based on the <I>Diagnostic and Statistical Manual of Mental Disorders</I> (DSM-III, IV, or R), the International Classification of Diseases (ICD-10) - or any other described criteria - , older than 18 years, of any ethnic group and nationality, regardless of comorbidities or use of concomitant medications for other diseases, with the exception of prior use of phosphodiesterase-5 inhibitors.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Any psychosocial intervention used for treating erectile dysfunction of at least four weeks duration. Psychosocial interventions may include any psycho-educative methods or psychotherapy of any kind, as long as they are described by the authors.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES>
<P>1. Effectiveness measured by:<BR/>a) changes in the status of illness, measured by validated questionnaires (e.g. International Index of Erectile Function, Golombok Rust Inventory of Sexual Satisfaction);<BR/>b) number of patients per treatment group who did not show successful sexual intercourse;<BR/>c) number of successful sexual intercourse;<BR/>d) relapse rates characterised by measures of erectile function status.</P>
<P>2. Treatment acceptability as measured by:<BR/>a) treatment compliance;<BR/>b) number of dropouts during the trial;<BR/>c) number of subjects who dropped out because of lack of efficacy or for feelings of worsening associated to psychosocial intervention;<BR/>d) attendance to psychosocial appointments.</P>
<P>3. Other:<BR/>a) quality of life;<BR/>b) satisfaction with the treatment;<BR/>c) improvement in depression or anxiety indices.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS>
<P>The following electronic databases were searched:<BR/> MEDLINE (1966 to 2007), EMBASE (1980 to 2007), PsycLIT (1974 to 2007), LILACS (1980 to 2007), the Cochrane Central Register of Controlled Trials (CENTRAL) (2007), and Dissertation Abstracts (2007). The 'optimal' MEDLINE, EMBASE and LILACS sensitive search strategies for identification of RCTs and systematic reviews were combined with the following phrases:<BR/>1. (erectile dysfunction*) OR (impoten* ) OR ( erection failure) OR (male sexual dysfunction)<BR/>2. psychotherap* OR (psychosocial intervention) OR (psychoeducation) OR (coping skills) OR (brief motivational counseling) OR ( sexual therapy) OR ( anxiety management training) OR (marital therapy) OR (group therapy) OR (cognitive therapy) OR (behavio* therapy) OR (focal therapy*) OR (general counseling) OR (psychodynamic therapy) OR (supportive therapy) OR (psychoanalyses) OR (interpersonal therapy) OR (cognitive therapy) OR (individual therapy) OR (couples therapy) OR (waiting list)<BR/>3. #1 AND #2</P>
<P>In addition we:<BR/>1) crosschecked references of all identified trials;<BR/>2) contacted with pharmaceutical companies in order to obtain data on unpublished trials;<BR/>3) contacted the first authors of all included trials to obtain further information or information regarding unpublished trials;<BR/>4) handsearched the <I>International Journal of Impotence Research</I> and <I>Journal of Sex and Marital Therapy</I> since its first issue; and <BR/>5) contacted scientific societies for ED.</P>
</SEARCH_METHODS>
<DATA_COLLECTION>
<P>Two reviewers (TM and BGOS) independently selected trials found with the search strategy, extracted the data, assessed trial quality and analysed the results. In case there were disagreements, the third reviewer (AGN) was consulted, and in the case consensus was not reached, data was not included in this review until the authors of the trial resolved the question.</P>
<P>SELECTION OF TRIALS<BR/>Reviewers screened the abstracts of all publications obtained by the search strategy. The articles potentially suitable for the review were obtained in full to assess relevance based on inclusion criteria.</P>
<P>QUALITY ASSESSMENT <BR/>The quality of each trial were based on the criteria of quality established in the <LINK REF="REF-Cochrane-Handbook" TYPE="REFERENCE">Cochrane Handbook</LINK>, which measures a wider range of factors, including:</P>
<P>1) minimisation of selection bias<BR/>a) was the randomisation procedure adequate?<BR/>b) was the allocation concealment adequate?</P>
<P>2) minimisation of attrition bias<BR/>a) were the withdrawals and dropouts described completely?<BR/>b) was analysis by intention to treat?</P>
<P>3) minimisation of detection bias <BR/>a) were outcome assessors blind to the intervention?</P>
<P>Based on this criteria, studies were classified according to criteria described in the <LINK REF="REF-Cochrane-Handbook" TYPE="REFERENCE">Cochrane Handbook</LINK>.<BR/>A - Low risk of bias (all the quality criteria met)<BR/>B - Moderate risk of bias (quality criteria partially met)<BR/>C - High risk of bias (one or more criteria not met)</P>
<P>DATA EXTRACTION<BR/>Intervention and outcomes were extracted independently by reviewers using a standard data extraction form.</P>
<P>ANALYSIS<BR/>Relative risks (RR) with 95% confidence intervals (CI) were estimated for dichotomous data using a fixed-effects model if no heterogeneity was present and according to an intention-to-treat analysis. If possible, the number needed to treat (NNT) and number needed to harm (NNH) were calculated.</P>
<P>Continuous outcomes were analysed if the mean and standard deviation of endpoint measures were presented in original articles. For the meta-analysis of continuous outcomes, weighted mean differences (WMD) between groups were estimated. Only nonskewed data are presented in this review.</P>
<P>Heterogeneity was assessed by chi-square test and was assumed to be present when significance was less than 0.1 (P &lt; 0.1). When significant heterogeneity was present, the random-effects model was applied and attempts were made to explain the differences based on clinical characteristics of the included studies and in the subgroup analysis. Potential publication bias was assessed by a funnel graph (trial effect versus trial size).</P>
<P>SUBGROUP ANALYSIS<BR/>Subgroups considered for evaluation included:<BR/>a) patients &lt; 40 years old versus patients &#8805; 40;<BR/>b) subjects with psychogenic erectile dysfunction versus organic ED versus mixed aetiology;<BR/>c) duration of follow up - 4 weeks versus 8 weeks versus 12 weeks versus 16 weeks versus 20 weeks versus 24 weeks or longer.</P>
</DATA_COLLECTION>
</METHODS>
<RESULTS>
<STUDY_DESCRIPTION MODIFIED="2008-03-24 13:26:18 -0500" MODIFIED_BY="[Empty name]">
<P>SEARCH</P>
<P>The search strategy generated 2184 references: MEDLINE (n = 1019); Cochrane Library (n = 78), EMBASE (n = 454), LILACS (n = 127), psycINFO (n = 501); and Dissertation Abstracts (n = 5). Two papers were identified by crosschecking references. Twenty-two full papers were evaluated and are listed in this review.<BR/>
<BR/>INCLUDED STUDIES</P>
<P>For detailed information see 'Table of included studies'.</P>
<P>Nine randomised controlled trials (<LINK REF="STD-Banner-2000" TYPE="STUDY">Banner 2000</LINK>; <LINK REF="STD-Baum-2000" TYPE="STUDY">Baum 2000</LINK>; <LINK REF="STD-Goldman-1990" TYPE="STUDY">Goldman 1990</LINK>; <LINK REF="STD-Kilmann-1987" TYPE="STUDY">Kilmann 1987</LINK>; <LINK REF="STD-Kockott-1975" TYPE="STUDY">Kockott 1975</LINK>; <LINK REF="STD-Melnik-2005" TYPE="STUDY">Melnik 2005</LINK>; <LINK REF="STD-Munjack-1984" TYPE="STUDY">Munjack 1984</LINK>; <LINK REF="STD-Price-1981" TYPE="STUDY">Price 1981</LINK>; <LINK REF="STD-Wylie-2003" TYPE="STUDY">Wylie 2003</LINK>) and two quasi-randomised trials (<LINK REF="STD-Ansari-1976" TYPE="STUDY">Ansari 1976</LINK>; <LINK REF="STD-Van-Der-Windt-2002" TYPE="STUDY">Van Der Windt 2002</LINK>) fulfilled the study inclusion criteria. Although no restrictions were made in terms of languages of original reports, all studies included were published in English.</P>
<P>
<B>Duration of trials</B>
<BR/>Duration of included trials covered 4 weeks to 12 months.</P>
<P>
<B>Participants</B>
<BR/>The 11 trials evaluated 398 men with a mean age 47.4 years old. Half of them were from the USA. Baseline ED severity was estimated in all trials. Diagnosis were stated as primary erectile dysfunction (n = 2) and secondary ED (n = 9). The most common range of age inclusion was 18 years and older, with ED of at least 3 to 6 months duration. Exclusion criteria applied in most trials included genital anatomic deformity, primary nonerectile sexual disorder (e.g., hypoactive sexual disorder), hyperprolactinaemia, hypogonadism, major psychiatric disorders not well controlled with therapy (including schizophrenia and major depression), and alcohol or substance abuse.</P>
<P>
<B>Types of interventions</B>
<BR/>Considering the diversity of psychosocial interventions, psychotherapy models were categorised according to their theoretical base, as described below.</P>
<P>a) Rational-Emotive Therapy (RET). Incorporating core elements of both behavioural and cognitive models, RET challenges negative automatic thoughts and dysfunctional underlying beliefs maintaining erectile dysfunction through collaborative 'hypothesis-testing', behavioural tasks, and skills training. A number of cognitive-behavioural therapies guided by manuals have been designed, including problem-solving therapy and self-control therapy, and are conducted over 12 to 16 sessions. Key elements of the model are psychoeducational and cognitive intervention, sexual and performance anxiety reduction, script assessment and modification, conflict resolution and relationship enhancement, and relapse-prevention training (<LINK REF="REF-Ellis-1992" TYPE="REFERENCE">Ellis 1992</LINK>).</P>
<P>b) Sex Group Therapy (GT). Developed specifically as a time-limited (8 - 16 sessions) therapy for erectile dysfunction. GT uses the connection between erectile dysfunction and current interpersonal experiences, and includes social skills training and homework assignments that address anxiety in sexual situations, education and information about male sexuality generally, communication training, myths about male sexuality, non-demand pleasuring, and permission to engage in self-pleasuring (<LINK REF="REF-Rosen-1995" TYPE="REFERENCE">Rosen 1995</LINK>).</P>
<P>c) Modified Masters Johnson Therapy. This approach is based on the notions that sexual dysfunction can have many causes, and can be tackled effectively with treatment programs that combine education, homework assignments and counseling (<LINK REF="REF-Masters-1970" TYPE="REFERENCE">Masters 1970</LINK>).</P>
<P>d) Educational Intervention. Workshops focused on disseminating information about psychological and physiological changes that occur during sexual response (<LINK REF="STD-Goldman-1990" TYPE="STUDY">Goldman 1990</LINK>).</P>
<P>e) Systematic desensitization. A behaviour therapy technique often used for the treatment of sexual dysfunction in which deep muscle relaxation is used to reduce the anxiety associated with certain situations (<LINK REF="REF-Rimm-1987" TYPE="REFERENCE">Rimm 1987</LINK>).</P>
<P>
<B>Setting</B>
<BR/>All studies included outpatients and were carried out in the United States of America (N = 6), Netherlands (N = 1), England (N = 2), Germany (N = 1), and Brazil (N = 1).</P>
<P>
<B>Sample size</B>
<BR/>Studies included between 16 and 70 participants.</P>
<P>EXCLUDED STUDIES</P>
<P>Five studies were excluded because they were not controlled studies (<LINK REF="STD-Hartmann-1993" TYPE="STUDY">Hartmann 1993</LINK>; <LINK REF="STD-Hawton-1986" TYPE="STUDY">Hawton 1986</LINK>; <LINK REF="STD-Reynolds-1981" TYPE="STUDY">Reynolds 1981</LINK>; <LINK REF="STD-Lobitz-1979" TYPE="STUDY">Lobitz 1979</LINK>; <LINK REF="STD-Zilbergeld-1975" TYPE="STUDY">Zilbergeld 1975</LINK>). Most were case reports or case series without a group control. Two studies was excluded because the patients had mixed sexual dysfunction that was not compatible with the review protocol (<LINK REF="STD-Golden-1978" TYPE="STUDY">Golden 1978</LINK>; <LINK REF="STD-Stravynski-1997" TYPE="STUDY">Stravynski 1997</LINK>).</P>
<P>AWAITING ASSESSMENT</P>
<P>Three studies (<LINK REF="STD-Phelps-2004" TYPE="STUDY">Phelps 2004</LINK>; <LINK REF="STD-Everaed-1985" TYPE="STUDY">Everaed 1985</LINK>; <LINK REF="STD-Takefman-1984" TYPE="STUDY">Takefman 1984</LINK>) are awaiting assessment. They all state that they are randomised controlled studies, but their outcomes could not be evaluated properly for the meta-analysis, mainly due to lack of information (no mention of mean and standard deviation for the main outcomes evaluated). First authors were contacted to seek additional information, but no relevant data were collected.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2008-03-24 13:27:21 -0500" MODIFIED_BY="[Empty name]">
<P>RANDOMISATION</P>
<P>From the nine trials that reported themselves as randomised, just three described a clearly adequate method of allocation concealment, with the use of sealed envelopes (<LINK REF="STD-Melnik-2005" TYPE="STUDY">Melnik 2005</LINK>; <LINK REF="STD-Wylie-2003" TYPE="STUDY">Wylie 2003;</LINK> <LINK REF="STD-Banner-2000" TYPE="STUDY">Banner 2000</LINK>). Therefore, a Cochrane quality criteria (<LINK REF="REF-Schulz-1995" TYPE="REFERENCE">Schulz 1995</LINK>) rating of 'A' was given for these studies. <LINK REF="STD-Ansari-1976" TYPE="STUDY">Ansari 1976</LINK> is a controlled study, using a quasi-randomisation method. In <LINK REF="STD-Van-Der-Windt-2002" TYPE="STUDY">Van Der Windt 2002</LINK>, the allocation procedure was done alternatively by a researcher.</P>
<P>BLINDNESS</P>
<P>Blindness is a difficult procedure in psychotherapy studies. There is the possibility of blinding the outcomes' evaluator, and this was described by <LINK REF="STD-Melnik-2005" TYPE="STUDY">Melnik 2005</LINK>. <LINK REF="STD-Munjack-1984" TYPE="STUDY">Munjack 1984</LINK>, <LINK REF="STD-Van-Der-Windt-2002" TYPE="STUDY">Van Der Windt 2002</LINK>, and <LINK REF="STD-Banner-2000" TYPE="STUDY">Banner 2000</LINK>.</P>
<P>
<LINK REF="STD-Melnik-2005" TYPE="STUDY">Melnik 2005</LINK> used independent researchers who were unaware of the patient's treatment allocation. <LINK REF="STD-Van-Der-Windt-2002" TYPE="STUDY">Van Der Windt 2002</LINK> used a challenge test that was conducted by a researcher who was blinded.</P>
<P>DESCRIPTION OF DROPOUTS</P>
<P>All the studies described those who dropped out before the end of the trial protocol. Dropout rates ranged from 0% (<LINK REF="STD-Kockott-1975" TYPE="STUDY">Kockott 1975</LINK>) to 52% (<LINK REF="STD-Baum-2000" TYPE="STUDY">Baum 2000</LINK>). The higher dropout rate compared psychotherapy with local injection (<LINK REF="STD-Baum-2000" TYPE="STUDY">Baum 2000</LINK>).</P>
<P>INTENTION TO TREAT ANALYSIS</P>
<P>Only one study (<LINK REF="STD-Wylie-2003" TYPE="STUDY">Wylie 2003</LINK>) carried out an intention-to-treat analysis.</P>
<P>OUTCOME REPORTING</P>
<P>Some outcomes could not be summarised because of poor description of outcomes in the main publications. In some situations there were no numbers; they were presented in graphical form only or with statistical language and P values. For many continuous variables standard deviations were not provided.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-03-24 13:28:20 -0500" MODIFIED_BY="[Empty name]">
<P>The 11 studies in this review (<LINK REF="STD-Ansari-1976" TYPE="STUDY">Ansari 1976</LINK>; <LINK REF="STD-Banner-2000" TYPE="STUDY">Banner 2000</LINK>; <LINK REF="STD-Baum-2000" TYPE="STUDY">Baum 2000</LINK>; <LINK REF="STD-Goldman-1990" TYPE="STUDY">Goldman 1990</LINK>; <LINK REF="STD-Kilmann-1987" TYPE="STUDY">Kilmann 1987</LINK>; <LINK REF="STD-Kockott-1975" TYPE="STUDY">Kockott 1975</LINK>; <LINK REF="STD-Melnik-2005" TYPE="STUDY">Melnik 2005</LINK>; <LINK REF="STD-Munjack-1984" TYPE="STUDY">Munjack 1984</LINK>; <LINK REF="STD-Price-1981" TYPE="STUDY">Price 1981</LINK>; <LINK REF="STD-Van-Der-Windt-2002" TYPE="STUDY">Van Der Windt 2002</LINK>; <LINK REF="STD-Wylie-2003" TYPE="STUDY">Wylie 2003</LINK>) examined eight comparisons. Some results could be pooled or summarised, as they were homogeneous. Intention-to-treat analysis was performed if all applicable data were available.</P>
<P>The following scales were used in included studies: International Index of Erectile Function (IIEF); Sexual Interaction Inventory (SII); ASKAS Knowledge Scale (AKLS); ASKAS Attitude Scale (AKAS); Fear of negative evaluation (FNE); and Success/experience patient weekly report form. For most of these scales data were skewed and could not be presented by graphical form or subject to meta-analysis. Many continuous outcomes were described with means without corresponding standard deviations.</P>
<P>GROUP PSYCHOTHERAPY (GT) VERSUS WAITING LIST (WT)</P>
<P>Group psychotherapy produced a statistically significant improvement in erectile function compared to control group (waiting list - no treatment). A meta-analysis of five trials comparing group therapy to control group (waiting list - no treatment) to evaluate the 'persistence of erectile dysfunction' found significant differences between group therapy and control group (RR 0.40, 95% CI 0.17 to 0.98, N = 100; NNT 1.61, 95% CI 0.97 to 4.76) (<LINK REF="STD-Kilmann-1987" TYPE="STUDY">Kilmann 1987</LINK>; <LINK REF="STD-Munjack-1984" TYPE="STUDY">Munjack 1984</LINK>; <LINK REF="STD-Price-1981" TYPE="STUDY">Price 1981</LINK>; <LINK REF="STD-Ansari-1976" TYPE="STUDY">Ansari 1976</LINK>; <LINK REF="STD-Kockott-1975" TYPE="STUDY">Kockott 1975</LINK>).</P>
<P>At six months follow up, there was a continued maintenance of reduction of men with "persistence of ED" in favour of psychotherapy (RR 0.43, 95% CI 0.26 to 0.72, N = 37; NNT 1.58, 95% CI 1.17 to 2.43) (<LINK REF="STD-Munjack-1984" TYPE="STUDY">Munjack 1984</LINK>; <LINK REF="STD-Price-1981" TYPE="STUDY">Price 1981</LINK>).</P>
<P>
<B>Subgroup analysis<BR/>
</B>
<BR/>
<B>
<I>Effectiveness by type of psychotherapy</I>
</B>
</P>
<P>
<I>Rational-emotive therapy (RET)<BR/>
</I>
<BR/>
<LINK REF="STD-Munjack-1984" TYPE="STUDY">Munjack 1984</LINK> conducted a study involving 16 self-referred men (aged 19 to 63, mean 47.5) presenting with secondary erectile failure. Subjects in this study were required to meet the following inclusion criteria: (a) "a primary complaint of erectile failure with satisfactory erections less than 25% of the time"; (b) persistent complaints of erectile problems for more than 6 months; (c) no organic etiology of erectile problems as judged by a medical evaluation, testosterone and prolactin levels, and the presence of morning erections; and (d) willingness to attend therapy sessions, screening, and assessment. Subjects were excluded from this study if they were taking psychoactive medication, undergoing psychiatric or psychological treatment, or if they had a history of homosexuality, drug abuse, alcoholism, schizophrenia, bipolar disorder, or other major psychiatric disorders.</P>
<P>Subjects in this study were randomly assigned to either a treatment group or a wait-list control (WLC) group. Treatment consisted of six weeks of biweekly rational-emotive therapy (RET) sessions designed to correct cognitive distortions that are hypothesized to hinder sexual functioning. Treatment was administered a by graduate student in psychology with specialty training in RET. Measures used in this study included a pretreatment assessment of the severity of the erectile disorder as evaluated using a ratio of successful attempts at intercourse compared to the total number of attempts. Numbers in this ratio were self-reported retrospectively for the two weeks prior to the assessment. During the treatment phase, subjects were required to compute the success/attempt ratio each week.</P>
<P>Data from the intercourse success/attempts ratio indicated that during the six-week course of the study in the treatment group all the subjects achieved successful intercourse and only one in the WLC during the study period. Furthermore, the reduction of men with "persistence of ED" favoured psychotherapy (RET) (RR 0.07, 95% CI, 0.00 to 1.00, N = 16, P = 0.05). Follow-up data for success/attempts ratios were collected for subjects in the RET group at six to nine months post-treatment and revealed that treatment gains were partially maintaining. Specifically, three subjects of the treatment group had ratio scores of 0%.</P>
<P>
<I>Sex-group therapy<BR/>
</I>
<BR/>
<LINK REF="STD-Price-1981" TYPE="STUDY">Price 1981</LINK> conducted a study involving 21 men without partners who presented with erectile difficulties. On the basis of medical consultation, it was determined that none of the subjects' erectile difficulties was attributable to organic aetiologies. Client selection criteria were as follows: (a) a presenting complaint of erectile dysfunction, defined by the male reporting dissatisfaction with his ability to obtain and/ or maintain erections; (b) the male had no steady sexual partner and was not dating at a frequency greater than twice per week; and (c) clients were willing to fulfil study requirements, including attendance at weekly sessions and completion of homework assignments and all questionnaires.</P>
<P>Treatment consisted of weekly, two-hour group sessions administered by two dual, sex-therapy teams. Authors reported that each session commenced with the collection of homework assignments from the previous week - including discussion of progress, problems and concerns -, presentation of didactic information, seeing films, role playing, and assignment of homework assignments to be completed prior to the next session. Authors provided an outline of the objectives of each session and associated homework assignments. For example, during session three the didactic presentations and discussion topics included presentation of female sexual anatomy and physiology and discussion of the use of fantasy. Homework following session three is described as "tactile exploration: personal erotic fantasy development and tactile exploration". Subjects were also asked to prepare maintenance programs in which they identified the original problems that brought them to treatment, the specific things that they had learned that was beneficial in the resolution of the problem, potential future problems, and potential solutions. It was reported that sessions were supplemented with bibliotherapy, but did not elaborate on the literature provided to subjects.</P>
<P>With regard to clinical outcomes, 14 of the 14 treatment subjects reported improvement with their erectile functioning. All 7 WLC members reported "no change".</P>
<P>Data were collected at six months following treatment. Ten of the 14 subjects in the treatment arm reported improvement in satisfaction with changes in erectile functioning compared with pretreatment functioning.</P>
<P>
<LINK REF="STD-Kilmann-1987" TYPE="STUDY">Kilmann 1987</LINK> studied the effects of three group treatment formats on 20 men with secondary erectile dysfunction. After a comprehensive medical and psychological screening, each couple was assigned to one of three treatment groups (Communication Technique Training, Sexual Technique Training, Combination Treatment) or to one of two control groups (Attention-Placebo, No Treatment). Couples in the three treatment groups and the attention-placebo group participated in their respective formats in twice weekly sessions for a total of 20 hours. The no-treatment control group received sex education and treatment after a five-week, waiting-list period.</P>
<P>Although these two studies individually failed to show significant differences favouring sex-group therapy over waiting list for "persistence of erectile dysfunction", the meta-analysis of these trials favoured the active intervention group (RR 0.13, 95% CI 0.04 to 0.43, N = 37),(<LINK REF="STD-Kilmann-1987" TYPE="STUDY">Kilmann 1987</LINK>; <LINK REF="STD-Price-1981" TYPE="STUDY">Price 1981</LINK>), with 95% of response for sex therapy and 0% for the waiting-list group (NNT 1.07, 95% CI 0.86 to 1.44).</P>
<P>The mean percentage per participant of intercourse attempts that were successful appeared greater for sex-group therapy compared to others types of group interventions (Rational-Emotive Therapy, Systematic Desensitization, Masters and Johnson Modified Therapy).<BR/>
<BR/>Three treatment groups (Masters and Johnson Modified Therapy (<LINK REF="STD-Ansari-1976" TYPE="STUDY">Ansari 1976</LINK>), Systematic Desensitization (<LINK REF="STD-Kockott-1975" TYPE="STUDY">Kockott 1975</LINK>), Rational-Emotive Therapy (<LINK REF="STD-Munjack-1984" TYPE="STUDY">Munjack 1984</LINK>)) demonstrated substantial gains in success/experience intercourse rates but were not statistically significant (respectively P = 0.14, P = 0.27, 1984, P = 0.05).</P>
<P>
<B>
<I>Effectiveness by the severity of erectile dysfunction</I>
</B>
</P>
<P>Men categorized at baseline as having primary ED appeared less likely than those with secondary ED to experience improved erections and successful sexual intercourse. However, for men in both categories of ED severity, primary (RR 0.57, 95% CI 0.40 to 0.82, N = 71) (<LINK REF="STD-Kockott-1975" TYPE="STUDY">Kockott 1975</LINK>; <LINK REF="STD-Ansari-1976" TYPE="STUDY">Ansari 1976</LINK>; <LINK REF="STD-Munjack-1984" TYPE="STUDY">Munjack 1984</LINK>) and secondary (RR 0.10, 95% CI 0.02 to 0.40, N = 29) (<LINK REF="STD-Price-1981" TYPE="STUDY">Price 1981</LINK>; <LINK REF="STD-Kilmann-1987" TYPE="STUDY">Kilmann 1987</LINK>), group therapy produced significantly better results than waiting list for "persistence of erectile dysfunction".</P>
<P>
<B>
<I>Effectiveness by the mean age of patients</I>
</B>
</P>
<P>In a subgroup analysis comparing one study with men between 30 and 39 years old (<LINK REF="STD-Kockott-1975" TYPE="STUDY">Kockott 1975</LINK>) to four studies with men aged 45 years and older (<LINK REF="STD-Price-1981" TYPE="STUDY">Price 1981</LINK>; <LINK REF="STD-Ansari-1976" TYPE="STUDY">Ansari 1976</LINK>; <LINK REF="STD-Kilmann-1987" TYPE="STUDY">Kilmann 1987</LINK>; <LINK REF="STD-Munjack-1984" TYPE="STUDY">Munjack 1984</LINK>), no statistical differences were identified.</P>
<P>
<B>
<I>Effectiveness according to partnership</I>
</B>
</P>
<P>In a subgroup analysis dividing studies with men with fixed partnerships (<LINK REF="STD-Ansari-1976" TYPE="STUDY">Ansari 1976</LINK>; <LINK REF="STD-Kilmann-1987" TYPE="STUDY">Kilmann 1987</LINK>; <LINK REF="STD-Munjack-1984" TYPE="STUDY">Munjack 1984</LINK>; <LINK REF="STD-Kockott-1975" TYPE="STUDY">Kockott 1975</LINK>) (P = 0.0006) and men without fixed partnerships (<LINK REF="STD-Price-1981" TYPE="STUDY">Price 1981</LINK>), only men without fixed partnership had a statistically significant difference (P = 0.02).</P>
<P>PSYCHO-EDUCATIONAL INTERVENTION VERSUS NO TREATMENT<B>
<BR/>
</B>
<BR/>
<LINK REF="STD-Goldman-1990" TYPE="STUDY">Goldman 1990</LINK> studied the effect of a psychoeducational intervention as an adjunct to treatment of erectile dysfunction in older couples. Twenty couples who presented to a multidisciplinary centre for erectile dysfunction were recruited for participation. Inclusion criteria were as follows: (a) between the ages of 55 and 75; (b) heterosexual; (c) in an ongoing relationship of at least six months duration; (d) had experienced secondary erectile dysfunction; and (e) exhibited no major psychiatric disorder or severe marital distress at initial evaluation.</P>
<P>Assessments were conducted at intake and immediately following treatment. A qualitative interview was also conducted with subjects in the treatment condition "at the time of follow-up". Treatment consisted of an educational workshop of unspecified length. The goals of the workshop were to (a) increase knowledge levels about the sexual response cycle and normal age-associated changes that occur in the cycle, (b) increase comfort levels with regard to the discussion of sexuality, (c) increase satisfaction with participants' expression of sexuality, and (d) increase participants' acceptance of their sexual difficulties.</P>
<P>Although the workshop group had improvement in the levels of ASKIS Knowledge Scale, data analysis revealed that the workshop participants reported no significant increases (WMD -5.65, 95% CI -14.74 to -3.44, N = 20).<BR/>
<BR/>Scores on the ASKAS Attitude Scale (WMD 0.70, 95% CI -23.28 to 24.68, N = 20) and the Sexual Interaction Inventory: mean pleasure (WMD 0.20, 95% CI -0.32 to - 0.72, N = 20) revealed no statistically significant changes in scores from pre- to post-treatment when comparing the workshop group to controls.</P>
<P>GROUP INTERVENTIONS</P>
<P>
<B>Systematic desensitization versus conventional medication plus general advice (routine group therapy) versus waiting list</B>
</P>
<P>
<LINK REF="STD-Kockott-1975" TYPE="STUDY">Kockott 1975</LINK> conducted a study to assess the therapeutic effectiveness of systematic desensitization of ED. Three groups of eight patients each were formed. They were treated with systematic desensitization or conventional medication plus general advice (routine group therapy), or put on a waiting list. Therapeutic effects were investigated on the behavioral, subjective, and physiological levels.</P>
<P>There were no significant differences among the systematic desensitization group and routine group therapy in "persistence of erectile dysfunction" (RR 1.00, 95% CI 0.47 to 2.14, N = 16, P = 1.00).</P>
<P>
<B>Group interventions versus drug therapy<BR/>
</B>
<BR/>
<B>
<I>Group therapy versus sildenafil citrate</I>
</B>
<I>
<BR/>
<BR/>
</I>One small study (<LINK REF="STD-Melnik-2005" TYPE="STUDY">Melnik 2005</LINK>) directly compared group therapy versus sildenafil citrate in the treatment of ED. This study found a significant difference favouring group therapy versus sildenafil in the mean score of the International Index of Erectile Function (IIEF) (WMD -12.40, 95% CI -20.81 to -3.99, N = 20, P = 0.004). Two of 10 patients (20%) reported "persistence of ED" in the psychotherapy group in post-treatment versus 6 of 10 (60%) in the sildenafil group. There was also a significant difference at three months follow up (WMD -9.67, 95% CI -17.03 to -2.31, N = 20), and for the numbers of dropouts - higher in sildenafil - between the two groups (WMD 0.38, 95% CI 0.05 to 2.77, N = 20).</P>
<P>
<B>
<I>Group therapy plus sildenafil citrate versus sildenafil citrate</I>
</B>
<I>
<BR/>
</I>
<BR/>Two studies (<LINK REF="STD-Banner-2000" TYPE="STUDY">Banner 2000</LINK>; <LINK REF="STD-Melnik-2005" TYPE="STUDY">Melnik 2005</LINK>) compared group therapy plus sildenafil citrate versus sildenafil citrate in the treatment of ED. The meta-analysis found a significant statistical difference between the two groups for successful attempts at intercourse, and favoured combined therapy (RR 0.46, 95% CI 0.24 to 0.88; NNT 3.57, 95% CI 2 to 16.7, N = 71). There was also a significant difference in the number of dropouts between the two groups, again favouring the combined therapy group (RR 0.29, 95% CI 0.09 to 0.93, N = 77).</P>
<P>
<B>
<I>Group therapy versus oxazepam</I>
</B>
</P>
<P>Little information is available regarding the efficacy of oxazepam for ED. Results from one trial (<LINK REF="STD-Ansari-1976" TYPE="STUDY">Ansari 1976</LINK>) did not reveal a statistical difference between group therapy versus oxazepam (RR 0.76, 95% CI 0.30 to 1.92, N = 37).</P>
<P>
<B>
<I>Intracavernosal injection (ICI) plus sex therapy (SC) versus ICI alone</I>
<BR/>
</B>
<BR/>
<LINK REF="STD-Van-Der-Windt-2002" TYPE="STUDY">Van Der Windt 2002</LINK> compared intracavernosal injection (ICI) therapy with and without sexological counseling in men with erectile dysfunction. In a randomised study men were alternately assigned to ICI without sexological counseling or with sexological counseling. In all, 70 patients were included, with 35 in each group. Fifty-seven (28 without SC, 29 with SC) were interviewed by telephone after a mean follow up of 11.3 months to determine their use of ICI and reasons for discontinuing.</P>
<P>There were no differences between the groups in discontinuation of ICI (overall 30%, P = 0.35), in reasons for discontinuing ICI (24% did so because of the return of spontaneous erections), or in sexual functioning.</P>
<P>In comparing "persistence of erectile dysfunction", no significant results were found (P = 0.24).</P>
<P>
<LINK REF="STD-Van-Der-Windt-2002" TYPE="STUDY">Van Der Windt 2002</LINK> presented data on "partners reporting the treatment to be disturbing", and found no differences between ICI and counseling (RR 1.29, 95% CI 0.39 to 4.33).</P>
<P>
<B>
<I>Sex therapy versus intracavernosal injection</I>
<BR/>
</B>
<BR/>
<LINK REF="STD-Baum-2000" TYPE="STUDY">Baum 2000</LINK> compared standard sex therapy versus self-injected, low-dose prostaglandin E1 (PGE1). Fifty men with psychogenic ED were divided into two groups: standard sex therapy for twelve weeks; or treatment using low dose (2.5 to 5.0 µg) PGE1.</P>
<P>For "persistence of erectile dysfunction" as well as dropout rates, there were no significant differences between groups (P = 0.25 and P = 0.40, respectively).</P>
<P>Sixty-nine percent of patients in the PGE1 group were satisfied with their treatment compared to 75% receiving sex therapy. There was no statistical difference (RR=0.81, 95% CI 0.25 to 2.64).</P>
<P>The frequency of intercourse reported in patient diaries for the two groups was similar (20.5 per month for PGE1 versus 20.0 per month for sex therapy). The reported duration of erection by patients receiving PGE1 therapy was longer than that reported by those receiving sex therapy (35 minutes versus 10 minutes).</P>
<P>One relevant aspect described in this study is a comparison of costs of treatment. Sex therapy was approximately 25% more expensive than the PGE1 treatment.</P>
<P>A meta-analysis of two trials comparing sex therapy to PGE1 (<LINK REF="STD-Baum-2000" TYPE="STUDY">Baum 2000</LINK>; <LINK REF="STD-Van-Der-Windt-2002" TYPE="STUDY">Van Der Windt 2002</LINK>) did not find a significantly statistical difference for "persistence of erectile dysfunction" (RR 1.11, 95% CI 0.62 to 1.97, N = 86). However, a trend was observed favouring sex therapy in <LINK REF="STD-Baum-2000" TYPE="STUDY">Baum 2000</LINK>.</P>
<P>
<B>
<I>Sex therapy versus vacuum devices</I>
<BR/>
</B>
<BR/>
<LINK REF="STD-Wylie-2003" TYPE="STUDY">Wylie 2003</LINK> studied 45 patients diagnosed with predominantly psychogenic erectile dysfunction. They were randomised to a vacuum constriction device (VCD) (N = 25) (also known as a vacuum erectile device) at the second session (group 1). The other group (N = 20) was randomised to psychotherapy without VCD.</P>
<P>Twenty-one couples (84%) in group 1 reported improvement after the initial psychotherapy and VCD sessions compared with group 2, in which 12 of the 20 couples (60%) reported improvement after couples psychotherapy. We subsequently found that three of the four couples in group 1 reporting no improvement had not used the pump provided.</P>
<P>Results did not reveal any difference between psychotherapy with VCD and psychotherapy without VCD after three weeks of treatment (RR 0.40, 95% CI 0.14 to 1.14, N = 45) and after six weeks of treatment (RR 0.27, 95% CI 0.01 to 6.27, N = 45).</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P>As far as we know this review is the first attempt of a meta-analysis of randomised controlled trials relevant to psychosocial interventions for erectile dysfunction.</P>
<P>This review confirmed that there is, in fact, a dearth of well-designed research on psychotherapy for erectile dysfunction. Our literature search identified around 2200 references on the topic, but only 11 studies could be re-analysed and presented by the criteria of random assignment and a controlled condition. Of the 22 studies eligible for inclusion, seven had methodological flaws or contained insufficient information to allow inclusion (<LINK REF="STD-Golden-1978" TYPE="STUDY">Golden 1978</LINK>; <LINK REF="STD-Hartmann-1993" TYPE="STUDY">Hartmann 1993</LINK>; <LINK REF="STD-Hawton-1986" TYPE="STUDY">Hawton 1986</LINK>; <LINK REF="STD-Lobitz-1979" TYPE="STUDY">Lobitz 1979</LINK>; <LINK REF="STD-Reynolds-1981" TYPE="STUDY">Reynolds 1981</LINK>; <LINK REF="STD-Stravynski-1997" TYPE="STUDY">Stravynski 1997</LINK>; <LINK REF="STD-Zilbergeld-1975" TYPE="STUDY">Zilbergeld 1975</LINK>).</P>
<P>General results of this systematic review found that group psychotherapy were effective in treating erectile dysfunction (<LINK REF="STD-Ansari-1976" TYPE="STUDY">Ansari 1976</LINK>; <LINK REF="STD-Kilmann-1987" TYPE="STUDY">Kilmann 1987</LINK>; <LINK REF="STD-Munjack-1984" TYPE="STUDY">Munjack 1984</LINK>; <LINK REF="STD-Price-1981" TYPE="STUDY">Price 1981</LINK>; <LINK REF="STD-Kockott-1975" TYPE="STUDY">Kockott 1975</LINK>). Related to the type of psychotherapy, two trials (<LINK REF="STD-Kilmann-1987" TYPE="STUDY">Kilmann 1987</LINK>; <LINK REF="STD-Price-1981" TYPE="STUDY">Price 1981</LINK>) showed the superiority of group therapy focused on sexuality. Sex therapy is a well established form of treatment (<LINK REF="REF-Masters-1970" TYPE="REFERENCE">Masters 1970</LINK>). Since then the treatment programme has been modified in various ways and other treatment approaches introduced (<LINK REF="REF-Rosen-2001" TYPE="REFERENCE">Rosen 2001</LINK>; <LINK REF="REF-LoPiccolo-1986" TYPE="REFERENCE">LoPiccolo 1986</LINK>).</P>
<P>Regarding subgroup analysis, no differences were found related to the severity of ED, type of partnership and mean group age. Although the potential roles of these differences in characteristics in the literature are negatively related to 'good prognosis' (<LINK REF="REF-Rosen-2001" TYPE="REFERENCE">Rosen 2001</LINK>), the variation in efficacy outcomes cannot be evaluated in the included studies. A range of factors makes it difficult to draw conclusions from the subgroup analysis, and include small samples sizes, differences in study design, definitions of outcome variables, and varying amounts of psychotherapy provided.</P>
<P>Only one study, <LINK REF="STD-Melnik-2005" TYPE="STUDY">Melnik 2005</LINK>, found a significant difference favouring group therapy versus sildenafil in mean score of IIEF. The rate of dropout was higher in the sildenafil group (4 versus 2). This result suggests despite the overall efficacy of sildenafil and its worth in treating ED, oral drug therapy is not always effective when used alone (<LINK REF="REF-Rosen-2001" TYPE="REFERENCE">Rosen 2001</LINK>; <LINK REF="REF-Althof-2002" TYPE="REFERENCE">Althof 2002</LINK>). Sometimes the single use can reveal or reinforce other sexual problems, such as lack of sexual desire and premature ejaculation. In some cases, other issues may come to light following unsuccessful or successful use of sildenafil (<LINK REF="REF-LoPiccolo-1986" TYPE="REFERENCE">LoPiccolo 1986</LINK>). For some couples sexual problems represents a neurotic reaction for deep relational conflicts, lack of communication, or power struggles, and drug therapy may not be a solution to these conflicts (<LINK REF="REF-Rosen-2001" TYPE="REFERENCE">Rosen 2001</LINK>).</P>
<P>Significant differences also were found in the rate of "persistence of erectile dysfunction" between group therapy plus sildenafil citrate and the sildenafil only for post-treatment (<LINK REF="STD-Banner-2000" TYPE="STUDY">Banner 2000</LINK>; <LINK REF="STD-Melnik-2005" TYPE="STUDY">Melnik 2005</LINK>). Strengths of these studies included inclusion of pretreatment assessments (careful clinical history and psychiatric evaluation, focused urological evaluation, and selected laboratory tests) and the use of blind raters.</P>
<P>One study, <LINK REF="STD-Ansari-1976" TYPE="STUDY">Ansari 1976</LINK>, compares benzodiazepines, particularly oxazepam versus psychotherapy, and found no difference between the two treatments.</P>
<P>Overall, no significant differences were found for any of the efficacy measures in comparison of sex therapy and ICI (<LINK REF="STD-Baum-2000" TYPE="STUDY">Baum 2000</LINK>; <LINK REF="STD-Van-Der-Windt-2002" TYPE="STUDY">Van Der Windt 2002</LINK>). However, satisfaction with treatment revealed that 69% of patients in the PGE1 group were satisfied with their treatment compared to 75% receiving sex therapy (<LINK REF="STD-Baum-2000" TYPE="STUDY">Baum 2000</LINK>).</P>
<P>Early combination treatment of psychotherapy plus a physical treatment such as VCD may lead to a beneficial response in men with ED compared to therapy alone. Eighty-four percent of couples reported some improvement after the initial psychotherapy and VCD sessions compared with 60% who reported some improvement in group 2 (<LINK REF="STD-Wylie-2003" TYPE="STUDY">Wylie 2003</LINK>). However, no significant differences were found for any of the efficacy measures between psychotherapy with VCD and psychotherapy without a VCD after three and six weeks of treatment.</P>
<P>Although we limited our analysis to randomised and quasi-randomised controlled trials, the majority of the studies had potential methodological flaws. Just three studies described a clearly adequate method of allocation concealment, with the use of sealed envelopes. Other limitations were related to small samples, limited length of follow up, validated outcomes, not reporting of intention-to-treat analyses, and variability in study design. Consequently, we were often unable to pool data, limiting our analyses to erectile dysfunction remission and dropout rates. We could not access important issues like improvement in quality of life and impact of the interventions in relationship satisfaction. Meta-analyses are less robust with small trials and thus the results should be interpreted with caution.</P>
<P>The availability of oral therapy has significantly altered the way in which erectile dysfunction is treated. While this medication is effective in restoring erectile function, it is often necessary to include the psychological and behavioural aspects of patients' diagnosis and management, as well as considering organic causes and risk factors. Integrating sex therapy and other psychological techniques into office practice will improve effectiveness in treating ED.</P>
<P>LACK OF DATA<B>
<BR/>
</B>
<BR/>Only eleven trials were identified that could be used in this systematic review. Five studies compared psychotherapy versus control group (waiting list - no treatment) (<LINK REF="STD-Price-1981" TYPE="STUDY">Price 1981</LINK>; <LINK REF="STD-Ansari-1976" TYPE="STUDY">Ansari 1976</LINK> <LINK REF="STD-Munjack-1984" TYPE="STUDY">Munjack 1984</LINK> ; <LINK REF="STD-Kilmann-1987" TYPE="STUDY">Kilmann 1987</LINK>; <LINK REF="STD-Kockott-1975" TYPE="STUDY">Kockott 1975</LINK>). One compared different types of psychotherapy (<LINK REF="STD-Kockott-1975" TYPE="STUDY">Kockott 1975</LINK>). Another compared psycho-educational interventions versus waiting list (<LINK REF="STD-Goldman-1990" TYPE="STUDY">Goldman 1990</LINK>). Three studies compared psychotherapy and drug therapy (<LINK REF="STD-Ansari-1976" TYPE="STUDY">Ansari 1976</LINK>; <LINK REF="STD-Melnik-2005" TYPE="STUDY">Melnik 2005</LINK>; <LINK REF="STD-Banner-2000" TYPE="STUDY">Banner 2000</LINK>), and two compared psychotherapy and intercavernous injections (<LINK REF="STD-Baum-2000" TYPE="STUDY">Baum 2000</LINK>; <LINK REF="STD-Van-Der-Windt-2002" TYPE="STUDY">Van Der Windt 2002</LINK>). Only one compared psychotherapy versus VCD (<LINK REF="STD-Wylie-2003" TYPE="STUDY">Wylie 2003</LINK>).<B>
<BR/>
</B>
</P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>Group psychotherapy improves erectile function in selected individuals. Treatment response seems to vary between patient subgroups, but focused sex group therapy showed greater efficacy than waiting list. In a meta-analysis that compared sildenafil versus group therapy plus sildenafil citrate, men randomised to receive group therapy showed significant improvement for successful intercourse and were less likely than those receiving only sildenafil to drop out. One study revealed that group psychotherapy had significantly higher scores compared with patients who were exclusively treated with sildenafil citrate. Regarding the effectiveness of psychosocial interventions for the treatment of ED compared to local injection, vacuum devices, and other psychological techniques, no differences were found.</P>
<P>With the evidence currently available, there are data supporting the efficacy of group therapy, in particular focused sex-group therapy. Further studies are required. We need large randomised trials with longer follow ups in order to examine whether psychosocial interventions alone help patients with erectile dysfunction. These studies would need to take account the study setting, as this may have a confounding effect on the results. The questions that should be raised are whether one psychosocial intervention is more effective than another. Does the effectiveness depend upon personality factors, psychiatric comorbid diagnosis, length of therapy time, severity of erectile dysfunction, or any other factors? The randomised trials should clearly state the method of randomisation, allocation concealment, blinding (where possible), perform intention-to-treat analysis, and with power calculations performed prior to the trial. More pragmatic studies can be designed and delivered that provide usable data for better understanding this important component of intervention in the field of ED.</P>
<P>Inherent problems in the of field erectile dysfunction are recruitment difficulties, motivation of patients, study adherence, blinding, follow-up difficulties, questionable results, high attrition rates, low study completion rates, and comparable, unintended selection of highly motivated patients.</P>
<P>Given the overall benefit of psychosocial interventions, the absence of a clear explanation about how they work means more work is urgently needed to identify which patient is likely to benefit most from what kind of treatment. At the clinical level, patient screening and selective assignment or referral for psychological therapy appears to be more cost efficient than giving all patients the same amount and type of intervention.</P>
<P>
<B>Implications for policy</B>
<BR/>Globally, great emphasis is placed on the vital role of psychosocial treatments for the management of erectile dysfunction. However, this is despite a dearth of good evidence on the overall value of psychosocial treatments. Policy makers need to ensure that a better evidence base is developed around psychosocial treatment to assist in the future rationale planning of interventions for erectile dysfunction.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>Well conducted and reported randomised controlled trials are essential to establish the effectiveness of psychosocial interventions for erectile dysfunction. </P>
<P>Large randomised trials with longer follow up to examine whether psychosocial interventions help patients with erectile dysfunction are needed. These studies would need to take account of the study setting as this may have a confounding effect on the results. The questions that should be raised are whether one psychosocial intervention is more effective than another. Does the effectiveness depend upon personality factors, psychiatric co-morbid diagnosis, length of therapy time, severity of erectile dysfunction use or any other factors?</P>
<P>The randomised trials should clearly state the method of randomisation, allocation concealment, blinding (where possible), perform intention-to-treat analysis, and with power calculations performed prior to the trial. More pragmatic studies can be designed and delivered that provide usable data for better understanding this important component of intervention in the field of sexuality.</P>
<P>Inherent problems in the of field of psychosocial interventions for sexual disorders are recruitment difficulties, motivation of patients, study adherence, blinding, follow-up difficulties, questionable results, high attrition rates, low study completion rates, and comparable, unintended selection of highly motivated patients.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS/>
<CONFLICT_OF_INTEREST>
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>TM - protocol writing, searching, trial selection, data extraction, completion of report</P>
<P>BGOS - protocol writing, searching, trial selection, data extraction, completion of report</P>
<P>AGN - trial selection, data extraction, expertise advice and completion of report</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES>
<STUDIES>
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Ansari-1976" NAME="Ansari 1976" YEAR="1976">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ansari JMA</AU>
<TI>Impotence : Prognosis ( a controlled study)</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1976</YR>
<VL>128</VL>
<PG>194-98</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Banner-2000" NAME="Banner 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="OTHER">
<TI>The effects of collaborative care in the treatment of erectile dysfunction (ED): an integrative treatment protocol (ITP)</TI>
<SO>The Fielding Institute</SO>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="UMI 9997519"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Baum-2000" NAME="Baum 2000" YEAR="2000">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Baum N; Randrup E, Junot D, Hass S</AU>
<TI>Prostragandin E1 versus sex therapy in the managment of psychogenic erectile dysfunction</TI>
<SO>Int J Impot Res</SO>
<YR>2000</YR>
<VL>12</VL>
<PG>191-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goldman-1990" NAME="Goldman 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goldman J, Carroll JL</AU>
<TI>Educational Intervention as an adjunct treatment of erectile dysfunction in older couples</TI>
<SO>Journal of Sex and Marital Therapy</SO>
<YR>1990</YR>
<VL>16</VL>
<PG>127-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kilmann-1987" NAME="Kilmann 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kilmann R P, Milan J R, Boland P J, Nankin R H, Davidson E, West O M, Sabalis R F, Caid C, Devine M J</AU>
<TI>Group treatment of secondary erectile dysfunction</TI>
<SO>Journal of Sex and Marital Therapy</SO>
<YR>1987</YR>
<VL>13</VL>
<PG>168-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kockott-1975" NAME="Kockott 1975" YEAR="1975">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kockott G, Dittmar F, Nusselt L</AU>
<TI>Systematic Desensitization of erectile impotence: a controlled study</TI>
<SO>Archives of Sexual Behavior</SO>
<YR>1975</YR>
<VL>4</VL>
<NO>5</NO>
<PG>493-500</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Melnik-2005" NAME="Melnik 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Melnik T</AU>
<TI>Psychogenic erectile dysfunction: comparative study of three therapeutic approches</TI>
<SO>Journal of Sex and Marital Therapy</SO>
<YR>2005</YR>
<VL>31</VL>
<NO>3</NO>
<PG>243-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Munjack-1984" NAME="Munjack 1984" YEAR="1984">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Munjack DJ, Schlaks A, Sanchez VC, Usigli R, Zulueta A, Leonard M</AU>
<TI>Rationale - emotive therapy in the treatment of erectile failure: an initial study</TI>
<SO>Journal of Sex and Marital Therapy</SO>
<YR>1984</YR>
<VL>10</VL>
<PG>170-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Price-1981" NAME="Price 1981" YEAR="1981">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Price CS, Reynolds RS, Cohen BD, Anderson AJ, Schochet BV</AU>
<TI>Group Treatment of Erectile Dsyfunction for men without partners: a controlled evaluation</TI>
<SO>Archives of Sexual Behavior</SO>
<YR>1981</YR>
<VL>10</VL>
<PG>253-268</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Van-Der-Windt-2002" NAME="Van Der Windt 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Van Der Windt F, Dohle GR, Van Der Tak J, Slob AK</AU>
<TI>Intracavernosal injectons therapy with or without sexological counselling in men with erectile dysfunction</TI>
<SO>BJU international</SO>
<YR>2002</YR>
<VL>89</VL>
<PG>901-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wylie-2003" NAME="Wylie 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wylie KR, Jones RH, Walters S</AU>
<TI>The potential benefit of vaccum devices augmenting psychosexual therapy for erectile dysfunction</TI>
<SO>Journal of Sex and Marital Therapy</SO>
<YR>2003</YR>
<VL>29</VL>
<PG>227-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Golden-1978" NAME="Golden 1978" YEAR="1978">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Golden JS, Price S, Heinrich AG, Lobitz WC</AU>
<TI>Group vs couple treatment of sexual dysfunctions</TI>
<SO>Archives of Sexual Behavior</SO>
<YR>1978</YR>
<VL>7</VL>
<PG>593-602</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hartmann-1993" NAME="Hartmann 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hartmann U, Langer D</AU>
<TI>Combination of psychosocial therapy and Intrapenile Injections in the treatment of erectile dysfunctions: rationale and predictors of outcome</TI>
<SO>Journal of Sex Education and Therapy</SO>
<YR>1993</YR>
<VL>19</VL>
<PG>1-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hawton-1986" NAME="Hawton 1986" YEAR="1986">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hawton K, Catalan J, Martin P, Fagg J</AU>
<TI>Long term outcome of sex therapy</TI>
<SO>Beh Res Ther</SO>
<YR>1986</YR>
<VL>24</VL>
<PG>665-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lobitz-1979" NAME="Lobitz 1979" YEAR="1979">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lobitz WC, Baker EL Jr</AU>
<TI>Group Treatment of single males with erectile dysfunction</TI>
<SO>Archives of Sexual Behavior</SO>
<YR>1979</YR>
<VL>8</VL>
<PG>127-38</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reynolds-1981" NAME="Reynolds 1981" YEAR="1981">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reynolds BS, Cohen BD, Schochet BV, Price SC, Anderson AJ</AU>
<TI>Dating skills training in the group treatment of erectile dysfunction men without partners</TI>
<SO>Journal of Sex and Marital Therapy</SO>
<YR>1981</YR>
<VL>7</VL>
<PG>184-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stravynski-1997" NAME="Stravynski 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stravynski A, Gaudette G, Lesage A, Petit N, Pascale C, Fabian J, Lamontagne Y, Langlois R, Lipp O, Sidoun P</AU>
<TI>The treatment of sexually dsyfunctional men without partners: a controlled study of three behavioural group approaches</TI>
<SO>The British Journal of Psychiatry</SO>
<YR>1997</YR>
<VL>170</VL>
<PG>338-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zilbergeld-1975" NAME="Zilbergeld 1975" YEAR="1975">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zilbergeld B</AU>
<TI>Group Treament of sexual dysfunction in men without partners</TI>
<SO>Journal of Sex and Marital Therapy</SO>
<YR>1975</YR>
<VL>1</VL>
<PG>204-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Everaed-1985" NAME="Everaed 1985" YEAR="1958">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Everaed W, Dekker J</AU>
<TI>Treatment of male sexual dysfunction: sex therapy compared with systematic desensitization and rational emotive therapy</TI>
<SO>Beh. Res. Ther</SO>
<YR>1985</YR>
<VL>23</VL>
<PG>13-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Phelps-2004" NAME="Phelps 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Phelps J, Jain A, Monga M</AU>
<TI>The PsychoedplusMed Approch to erectile dysfunction treatment: the impact of combining a psychoeducacional intervention with sildenafil</TI>
<SO>Journal of Sex and Marital Therapy</SO>
<YR>2004</YR>
<VL>30</VL>
<PG>305-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Takefman-1984" NAME="Takefman 1984" YEAR="1984">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Takefman J, Brender W</AU>
<TI>An analysis of the effectiveness of two components in the treatment of erectile dysfunction</TI>
<SO>Archives of Sexual Behavior</SO>
<YR>1984</YR>
<VL>13</VL>
<PG>321-39</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES>
<ADDITIONAL_REFERENCES>
<REFERENCE ID="REF-Ackerman-1995" NAME="Ackerman 1995" TYPE="JOURNAL_ARTICLE">
<AU>Ackerman MD, Carey MP</AU>
<TI>Psychologys role in the assessment of erectile dysfunction: historical precedents, current knowledge and methods</TI>
<SO>Consult Clin Psychol</SO>
<YR>1995</YR>
<VL>63</VL>
<PG>862-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Althof-1989" NAME="Althof 1989" TYPE="BOOK_SECTION">
<AU>Althof S</AU>
<TI>Psychogenic impotence: treatment of men and couples</TI>
<SO>Principles and practice of sex therapy: update for the 1990s</SO>
<YR>1989</YR>
<PG>237-65</PG>
<PB>Guilford</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Althof-2000" NAME="Althof 2000" TYPE="JOURNAL_ARTICLE">
<AU>Althof S</AU>
<TI>The patient with erectile dysfunction: psychological issues</TI>
<SO>Nurse Pract</SO>
<YR>2000</YR>
<VL>Suppl 1</VL>
<PG>11-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Althof-2002" NAME="Althof 2002" TYPE="JOURNAL_ARTICLE">
<AU>Althof S</AU>
<TI>When an erection alone is not enough: biopsychosocial obstacles to lovemaking</TI>
<SO>Int J Impot Res</SO>
<YR>2002</YR>
<VL>14 Suppl 1</VL>
<PG>99-104</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Aydin-2001" NAME="Aydin 2001" TYPE="JOURNAL_ARTICLE">
<AU>Aydin S, Unal D, Erol H, Karaman I, Yilmaz Y, Sengul E, Bayrakli H</AU>
<TI>Multicentral clinical evaluation of etiology of erectile dysfunction: a survey report</TI>
<SO>Int Urol Nephrol</SO>
<YR>2001</YR>
<VL>32</VL>
<PG>213-217</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cochrane-Handbook" NAME="Cochrane Handbook" TYPE="OTHER">
<TI>Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]</TI>
<SO>In: The Cochrane Library</SO>
<YR>2006</YR>
<NO>4</NO>
<ED>Higgins JPT, Green S</ED>
<PB>John Wiley &amp; Sons, Ltd.</PB>
<CY>Chichester</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ellis-1992" NAME="Ellis 1992" TYPE="JOURNAL_ARTICLE">
<AU>Ellis A</AU>
<TI>Links Group rational-emotive and cognitive-behavioral therapy</TI>
<SO>Int J Group Psychother</SO>
<YR>1992</YR>
<VL>42</VL>
<NO>1</NO>
<PG>63-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Feldman-1994" NAME="Feldman 1994" TYPE="JOURNAL_ARTICLE">
<AU>Feldman HA, Goldstein I, Hatzichristou DG, Kranes RJ, Makinlay JB</AU>
<TI>Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study</TI>
<SO>J Urol</SO>
<YR>1994</YR>
<VL>151</VL>
<NO>1</NO>
<PG>151-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Levine-2000" NAME="Levine 2000" TYPE="JOURNAL_ARTICLE">
<AU>Levine LA</AU>
<TI>Diagnosis and treatment of erectile dysfunction</TI>
<SO>Am J Med</SO>
<YR>2000</YR>
<VL>Suppl 9A Discussion</VL>
<PG>29S- 30S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-LoPiccolo-1986" NAME="LoPiccolo 1986" TYPE="JOURNAL_ARTICLE">
<AU>LoPiccolo J, Stock WE</AU>
<TI>Treatment of sexual dysfunction</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>1986</YR>
<VL>54</VL>
<PG>158-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Masters-1970" NAME="Masters 1970" TYPE="BOOK">
<AU>Masters WH, Johnson VE</AU>
<SO>Human Sexual Inadequacy</SO>
<YR>1970</YR>
<PB>Little, Brown</PB>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="ISBN 055326317X"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Melman-1988" NAME="Melman 1988" TYPE="JOURNAL_ARTICLE">
<AU>Melman A, Tiefer L, Pederson R</AU>
<TI>Evaluation of first 406 patients in urology department based center for male sexual dysfunction</TI>
<SO>Urology</SO>
<YR>1988</YR>
<VL>32</VL>
<PG>6-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NIH-1992" NAME="NIH 1992" TYPE="CONFERENCE_PROC">
<AU>Anonymous</AU>
<TI>Impotence. NIH Consens Statement</TI>
<SO>National Institutes of Health Consensus Development Conference Statement</SO>
<YR>1992</YR>
<VL>10</VL>
<NO>4</NO>
<PG>1-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Perelman-2001" NAME="Perelman 2001" TYPE="JOURNAL_ARTICLE">
<AU>Perelman MA</AU>
<TI>The impact of new sexual pharmaceuticals on sex therapy</TI>
<SO>Curr Psychiatry Rep</SO>
<YR>2001</YR>
<VL>3</VL>
<PG>195-201</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rimm-1987" NAME="Rimm 1987" TYPE="BOOK">
<AU>Rimm DC, Masters JC</AU>
<SO>Behavior therapy: Techniques and empirical findings</SO>
<YR>1987</YR>
<PB>Academic Press</PB>
<CY>NY</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rosen-1995" NAME="Rosen 1995" TYPE="JOURNAL_ARTICLE">
<AU>Rosen RC, Leiblum SR</AU>
<TI>Treatment of sexual disorders in the 1990s: an integrated approach</TI>
<SO>J Consult Clin Psychol</SO>
<YR>1995</YR>
<VL>63</VL>
<NO>6</NO>
<PG>877-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rosen-2001" NAME="Rosen 2001" TYPE="JOURNAL_ARTICLE">
<AU>Rosen RC</AU>
<TI>Psychogenic erectile dysfunction: classification and management</TI>
<SO>Urol Clin North Am</SO>
<YR>2001</YR>
<VL>28</VL>
<PG>269-78</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schulz-1995" NAME="Schulz 1995" TYPE="JOURNAL_ARTICLE">
<AU>Schulz KF, Chalmers I, Hayes RJ, Altman DG</AU>
<TI>Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials</TI>
<SO>JAMA</SO>
<YR>1995</YR>
<VL>273</VL>
<NO>5</NO>
<PG>408-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Seidman-2001" NAME="Seidman 2001" TYPE="JOURNAL_ARTICLE">
<AU>Seidman SN, Roose SP</AU>
<TI>Sexual dsyfunction and depression</TI>
<SO>Curr Psychiatry Rep</SO>
<YR>2001</YR>
<VL>3</VL>
<PG>202-8</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Ansari-1976">
<CHAR_METHODS>
<P>Allocation: quasi-randomised<BR/>Analysis: non ITT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>N= 61 (55)<BR/>Age= group I -mean 29 y , group II- mean 46.4, group III- 45.0<BR/>Diagnosis: psychogenic erectile and mixed factors<BR/>Centres:England</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1. Oxazepam 30-90 mg/day (N=16 )<BR/>2. Modifed Masters technique (n=21)<BR/>3. No treatment (N=18 )</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>- Dropout<BR/>-Persistence of erectile dysfunction<BR/>- Not recovered<BR/>- Not improved</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Banner-2000">
<CHAR_METHODS>
<P>Allocation: randomised<BR/>Evaluator blind</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>N= 57 couples (50)<BR/>Age=group I- 55.3 yr<BR/>group II -57.2 yr<BR/>Diagnosis: psychogenic erectile dysfunction<BR/>Centres: USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1. sildenafil 50 mg (n=27)<BR/>2. sildenafil 50mg plus cognitive behavioral sex therapy (n=30)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>- Dropout <BR/>- Persistence of erectile dysfunction<BR/>- IIFE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Baum-2000">
<CHAR_METHODS>
<P>Allocation: randomised<BR/>Blindness: none<BR/>Analysis: non ITT<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>N= 50<BR/>Age: PGE1 group mean age= 49.6 ST mean age= 50.1<BR/>Diagnosis: psychogenic erectile dysfunction<BR/>Centres: Los Angeles</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1. Sex therapy-weekly sessions during 12 weeks (N=25)<BR/>2. PGE1 low dose (2.5-5.0) (N=25)<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>- Dropout<BR/>- Sex situations producing erections<BR/>- Satisfation with the treatment<BR/>- confidence in performance after 6 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Goldman-1990">
<CHAR_METHODS>
<P>Allocation: randomised<BR/>Blindness: none<BR/>Analysis: none ITT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>N= 20 couples<BR/>Age= mean 61 years<BR/>Diagnosis: secondary ED<BR/>Centres: Philadelphia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1. Workshop (N=10)<BR/>2. Control (N=10)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Sexual Interaction Inventory (SII);<BR/>Frequency of Sexual Behavior Form (SSBF);<BR/>Aging Sexual Knowledge and Attitude (ASKAS)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kilmann-1987">
<CHAR_METHODS>
<P>Allocation: randomised<BR/>Blindness: none<BR/>Analysis:none ITT<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>N= 20 couples<BR/>age= mean avarage 51y (31-67)<BR/>Centres:Columbia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1. Comunication techniques training (CTT) (N=4 couples)<BR/>2. Sexual techniques training (STT) (N=4)<BR/>3. Combination (CTT + STT) (N=4)<BR/>3. Attention- placebo (control group) (N=4)<BR/>4. No treatment (N=4)<BR/>Setting: Columbia</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>- MAT <BR/>- SII<BR/>- Coital Success<BR/>- SAI<BR/>- SPR</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kockott-1975">
<CHAR_METHODS>
<P>Allocation:<BR/>randomised<BR/>Blindeness: none<BR/>Analysis: none ITT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>N= 24 men with a partnership<BR/>age= mean 31<BR/>Diagnosis= ED<BR/>Centres:Germany</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1. Behavior therapy group (14 sessions of systematic desensitization) (N=8)<BR/>2. Routine therapy seen by psychiatrists 4 times at intervals of 3-5 weeks (N=8)<BR/>3. Waiting list (N=8)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>-Droup out<BR/>-Persistence of erectile dysfunction<BR/>-semi-structured interview<BR/>- Persistence of erectile dysfunction</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Melnik-2005">
<CHAR_METHODS>
<P>Allocation:<BR/>randomised ( sealed envelope method)<BR/>evaluator blind the outcomes<BR/>Analysis: none ITT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>N=30<BR/>mean age= 39.74<BR/>Diagnosis= psychogenic ED<BR/>Centres: Brazil</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1. group therapy ( weekly sessions for 6 months) plus 50mg sidenafil citrate orally on demand for 6 months;<BR/>2. 50 mg sildenafil citrate orally on demand for 6 months;<BR/>3. group therapy (weekly sessions for 6 months)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>- Droup out<BR/>-Persistence of erectile dysfunction<BR/>- IIFE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Munjack-1984">
<CHAR_METHODS>
<P>Allocation:randomised<BR/>Blindeness: evaluator blind the outcomes<BR/>Analysis: none ITT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>N= 16 married or living with their sexual partners<BR/>age= 19- 63( mean 47.5 y)<BR/>Centres :Los Angeles</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1.12 bi- weekly rational- emotive therapy sessions (6 weeks) Vs 2. 6 weeks waiting list</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>-Persitence of erectile dysfunction<BR/>- Sex attempts</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Price-1981">
<CHAR_METHODS>
<P>Allocation: randomised<BR/>Blindness: none<BR/>Analysis: none ITT<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>N= 21men who had no steady sexual partner<BR/>age= 25-61(mean 45.4)<BR/>Diagnosis: secondary ED<BR/>Centres: Los Angeles</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1. 8 weekly 2- hour sessions of group therapy (conducted by dual sex therapists) Vs 2. waiting list<BR/>Duration = Couples in the 5 groups had twice-weekly sessions for a total of 20 hours</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>-Persistence of erectile dysfunction<BR/>attempts of sexual intercourse</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Van-Der-Windt-2002">
<CHAR_METHODS>
<P>Allocation: Allocation: randomised (alternately assigned by a medical secretary)<BR/>Analysis: non ITT<BR/>Duration: 6 months follow up<BR/>Analysis: none ITT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>N= 70 (57 analysed)<BR/>age=23-75 (mean 56 years)<BR/>excluded= major organic cases for ED (all etiologies)<BR/>Setting= urology clinic<BR/> Centres: Netherlands<BR/>duration= april 1998 to August 1999<BR/>history= social - relational and psycho-medical history. A questionnarie, VSS and VSS + estimulation</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1. ICI (androskat 0,25 mL) with SC<BR/>(n=28)</P>
<P>2. ICI without SC (n=29)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>- Droup out (discontinuation of ICI)<BR/> - non fully penile erection<BR/>- partners reporting the treatment to be disturbing</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wylie-2003">
<CHAR_METHODS>
<P>Allocation:<BR/>randomised ( sealed envelope method)<BR/>Blindeness: none<BR/>Analysis: non ITT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>N= 45 couples<BR/>age= 40<BR/>Diagnosis: psychogenic ED and mixeed aethology<BR/>setting: England</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1. Relationship therapy and Masters Sex therapy (each session lasted 40-50 min every 2 weeks)</P>
<P>2. Therapy plus VCD at the session</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Response to treatment as assesed by therapist</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ED - Erectile Dysfunction<BR/>ICI- Intracavernosal injection<BR/>ITT - Intention to Treat<BR/>MAT - Marital Adjustment Test<BR/>PGE - Prostaglandin<BR/>SAI - Sex Anxiety Inventory<BR/>SII - Sexual Interaction Inventory<BR/>SPR - Sexual Pleasure Rating</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Golden-1978">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: RCT<BR/>Participants: mixed sexual dysfunctions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hartmann-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, case series</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hawton-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, case series</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lobitz-1979">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, case series</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Reynolds-1981">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, case series</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Stravynski-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Participants: mixed sexual dysfunctions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zilbergeld-1975">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, case series</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR STUDY_ID="STD-Everaed-1985">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Phelps-2004">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Takefman-1984">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="NO" STUDY_ID="STD-Ansari-1976">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Banner-2000">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Baum-2000">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Goldman-1990">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kilmann-1987">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kockott-1975">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Melnik-2005">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Munjack-1984">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Price-1981">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Van-Der-Windt-2002">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Wylie-2003">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES">
<COMPARISON ID="CMP-001" NO="1">
<NAME>GROUP THERAPY (GT) VERSUS WAITING LIST (WT)</NAME>
<DICH_OUTCOME CHI2="16.46982915108134" CI_END="0.7811151977340884" CI_START="0.26081726667099153" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4513627486049065" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="55" I2="63.56974960116045" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-0.10728491228031259" LOG_CI_START="-0.5836636607479859" LOG_EFFECT_SIZE="-0.3454742865141493" METHOD="MH" NO="1" P_CHI2="0.011442504697158906" P_Q="0.0" P_Z="0.004472359600193211" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.2802227514840036" TOTALS="SUB" TOTAL_1="77" TOTAL_2="60" WEIGHT="200.0" Z="2.842768118143091">
<NAME>persistence of erectile dysfunction</NAME>
<GROUP_LABEL_1>group therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>waiting list</GROUP_LABEL_2>
<GRAPH_LABEL_1>group therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>waiting list</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="15.278242080697314" CI_END="0.9770659764891517" CI_START="0.16509333223901854" DF="4.0" EFFECT_SIZE="0.40163052408397026" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="40" I2="73.81897747873991" ID="CMP-001.01.01" LOG_CI_END="-0.010076109507689515" LOG_CI_START="-0.7822704665935182" LOG_EFFECT_SIZE="-0.3961732880506038" NO="1" P_CHI2="0.0041575992797237005" P_Z="0.044313434502991036" STUDIES="5" TAU2="0.5752275307561009" TOTAL_1="55" TOTAL_2="45" WEIGHT="100.0" Z="2.0111138318761133">
<NAME>post-treatment</NAME>
<DICH_DATA CI_END="1.1016071659441518" CI_START="0.5009378585704063" EFFECT_SIZE="0.7428571428571429" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="15" LOG_CI_END="0.04202675233953586" LOG_CI_START="-0.3002161450984511" LOG_EFFECT_SIZE="-0.12909469637945764" ORDER="2599" O_E="0.0" SE="0.20103517208473848" STUDY_ID="STD-Ansari-1976" TOTAL_1="21" TOTAL_2="18" VAR="0.04041514041514041" WEIGHT="38.956612728917314"/>
<DICH_DATA CI_END="1.312332503184805" CI_START="0.08466688955844923" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.1180438853468899" LOG_CI_START="-1.072286394786215" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="2600" O_E="0.0" SE="0.699205898780101" STUDY_ID="STD-Kilmann-1987" TOTAL_1="4" TOTAL_2="4" VAR="0.4888888888888889" WEIGHT="16.240771203092635"/>
<DICH_DATA CI_END="1.2979384535601666" CI_START="0.3930880391386773" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.11325409931109688" LOG_CI_START="-0.405510170667573" LOG_EFFECT_SIZE="-0.146128035678238" ORDER="2601" O_E="0.0" SE="0.304724700110022" STUDY_ID="STD-Kockott-1975" TOTAL_1="8" TOTAL_2="8" VAR="0.09285714285714286" WEIGHT="33.480673631556236"/>
<DICH_DATA CI_END="1.0014627490096395" CI_START="0.004437952833332663" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="6.347996601127133E-4" LOG_CI_START="-2.352817317771475" LOG_EFFECT_SIZE="-1.1760912590556813" ORDER="2602" O_E="0.0" SE="1.3824294235551813" STUDY_ID="STD-Munjack-1984" TOTAL_1="8" TOTAL_2="8" VAR="1.911111111111111" WEIGHT="5.700165727434534"/>
<DICH_DATA CI_END="0.5457618720039037" CI_START="0.0023163903447897044" EFFECT_SIZE="0.035555555555555556" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="-0.2629968082716766" LOG_CI_START="-2.6351882539671614" LOG_EFFECT_SIZE="-1.449092531119419" ORDER="2603" O_E="0.0" SE="1.3934369977385652" STUDY_ID="STD-Price-1981" TOTAL_1="14" TOTAL_2="7" VAR="1.9416666666666664" WEIGHT="5.621776708999284"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.9112600961877113" CI_END="0.7164475649500115" CI_START="0.25684494301014393" DF="1.0" EFFECT_SIZE="0.4289707845405583" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="15" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="-0.14481558905752412" LOG_CI_START="-0.5903289806284117" LOG_EFFECT_SIZE="-0.3675722848429679" NO="2" P_CHI2="0.33978043037705263" P_Z="0.0012200560370409245" STUDIES="2" TAU2="0.0" TOTAL_1="22" TOTAL_2="15" WEIGHT="100.0" Z="3.2341494268761375">
<NAME>at 6 months follow up</NAME>
<DICH_DATA CI_END="1.0369392383404392" CI_START="0.27029242046772506" EFFECT_SIZE="0.5294117647058824" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.015753308725986764" LOG_CI_START="-0.5681661326038848" LOG_EFFECT_SIZE="-0.27620641193894907" ORDER="2604" O_E="0.0" SE="0.3429971702850177" STUDY_ID="STD-Munjack-1984" TOTAL_1="8" TOTAL_2="8" VAR="0.11764705882352944" WEIGHT="52.746012398966165"/>
<DICH_DATA CI_END="0.7075278494690481" CI_START="0.14472928532331875" EFFECT_SIZE="0.32" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="-0.15025646091647593" LOG_CI_START="-0.8394435824437122" LOG_EFFECT_SIZE="-0.494850021680094" ORDER="2605" O_E="0.0" SE="0.4048319267163706" STUDY_ID="STD-Price-1981" TOTAL_1="14" TOTAL_2="7" VAR="0.16388888888888886" WEIGHT="47.25398760103383"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="15.278242080697314" CI_END="0.6126583482466363" CI_START="0.30258568664598406" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4305596903840429" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="40" I2="73.81897747873991" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-0.21278164429923704" LOG_CI_START="-0.5191516194644795" LOG_EFFECT_SIZE="-0.3659666318818583" METHOD="MH" NO="2" P_CHI2="0.0041575992797237005" P_Q="0.0" P_Z="2.834629766815951E-6" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="55" TOTAL_2="45" WEIGHT="400.0" Z="4.682452434478937">
<NAME>persistence of erectile dysfunction - according to type of group intervention</NAME>
<GROUP_LABEL_1>group therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>waiting list</GROUP_LABEL_2>
<GRAPH_LABEL_1>group therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>waiting list</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.00146274900964" CI_START="0.004437952833332658" DF="0.0" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" I2="0.0" ID="CMP-001.02.01" LOG_CI_END="6.347996601129059E-4" LOG_CI_START="-2.3528173177714753" LOG_EFFECT_SIZE="-1.1760912590556813" NO="1" P_CHI2="1.0" P_Z="0.050123719251995484" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="1.9589066573380227">
<NAME>rational emotive therapy</NAME>
<DICH_DATA CI_END="1.0014627490096395" CI_START="0.004437952833332663" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="6.347996601127133E-4" LOG_CI_START="-2.352817317771475" LOG_EFFECT_SIZE="-1.1760912590556813" ORDER="2606" O_E="0.0" SE="1.3824294235551813" STUDY_ID="STD-Munjack-1984" TOTAL_1="8" TOTAL_2="8" VAR="1.911111111111111" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.6913468526683952" CI_END="0.4298988363693509" CI_START="0.038935059500334455" DF="1.0" EFFECT_SIZE="0.1293759512937595" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="11" I2="62.8438824595006" ID="CMP-001.02.02" LOG_CI_END="-0.366633730409985" LOG_CI_START="-1.4096591572809913" LOG_EFFECT_SIZE="-0.888146443845488" NO="2" P_CHI2="0.10089456341460112" P_Z="8.442708170393716E-4" STUDIES="2" TAU2="0.0" TOTAL_1="18" TOTAL_2="11" WEIGHT="100.0" Z="3.3378573486104743">
<NAME>sex group therapy</NAME>
<DICH_DATA CI_END="1.312332503184805" CI_START="0.08466688955844923" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.1180438853468899" LOG_CI_START="-1.072286394786215" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="2607" O_E="0.0" SE="0.699205898780101" STUDY_ID="STD-Kilmann-1987" TOTAL_1="4" TOTAL_2="4" VAR="0.4888888888888889" WEIGHT="31.506849315068493"/>
<DICH_DATA CI_END="0.5457618720039037" CI_START="0.0023163903447897044" EFFECT_SIZE="0.035555555555555556" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="-0.2629968082716766" LOG_CI_START="-2.6351882539671614" LOG_EFFECT_SIZE="-1.449092531119419" ORDER="2608" O_E="0.0" SE="1.3934369977385652" STUDY_ID="STD-Price-1981" TOTAL_1="14" TOTAL_2="7" VAR="1.9416666666666664" WEIGHT="68.4931506849315"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2979384535601666" CI_START="0.3930880391386773" DF="0.0" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" I2="0.0" ID="CMP-001.02.03" LOG_CI_END="0.11325409931109688" LOG_CI_START="-0.405510170667573" LOG_EFFECT_SIZE="-0.146128035678238" NO="3" P_CHI2="1.0" P_Z="0.26951320633089026" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="1.1041843227665114">
<NAME>systematic desensitization</NAME>
<DICH_DATA CI_END="1.2979384535601666" CI_START="0.3930880391386773" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.11325409931109688" LOG_CI_START="-0.405510170667573" LOG_EFFECT_SIZE="-0.146128035678238" ORDER="2609" O_E="0.0" SE="0.304724700110022" STUDY_ID="STD-Kockott-1975" TOTAL_1="8" TOTAL_2="8" VAR="0.09285714285714286" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1016071659441518" CI_START="0.5009378585704063" DF="0.0" EFFECT_SIZE="0.7428571428571429" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="15" I2="0.0" ID="CMP-001.02.04" LOG_CI_END="0.04202675233953586" LOG_CI_START="-0.3002161450984511" LOG_EFFECT_SIZE="-0.12909469637945764" NO="4" P_CHI2="1.0" P_Z="0.1392460315472375" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="18" WEIGHT="100.0" Z="1.4786045664817145">
<NAME>Masters and Johnson Modifed technique</NAME>
<DICH_DATA CI_END="1.1016071659441518" CI_START="0.5009378585704063" EFFECT_SIZE="0.7428571428571429" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="15" LOG_CI_END="0.04202675233953586" LOG_CI_START="-0.3002161450984511" LOG_EFFECT_SIZE="-0.12909469637945764" ORDER="2610" O_E="0.0" SE="0.20103517208473848" STUDY_ID="STD-Ansari-1976" TOTAL_1="21" TOTAL_2="18" VAR="0.04041514041514041" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="15.278242080697312" CI_END="0.6126583482466363" CI_START="0.30258568664598406" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4305596903840429" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="40" I2="73.8189774787399" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-0.21278164429923704" LOG_CI_START="-0.5191516194644795" LOG_EFFECT_SIZE="-0.3659666318818583" METHOD="MH" NO="3" P_CHI2="0.004157599279723145" P_Q="0.0" P_Z="2.834629766815951E-6" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="55" TOTAL_2="45" WEIGHT="200.0" Z="4.682452434478937">
<NAME>persistence of erectile dysfunction - according the severity of ED</NAME>
<GROUP_LABEL_1>group therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>waiting list</GROUP_LABEL_2>
<GRAPH_LABEL_1>group therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>waiting list</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.669323628558146" CI_END="0.8195175974996021" CI_START="0.3976929268331123" DF="2.0" EFFECT_SIZE="0.5708908406524467" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="29" I2="57.16724392869754" ID="CMP-001.03.01" LOG_CI_END="-0.08644171638888391" LOG_CI_START="-0.400452133089116" LOG_EFFECT_SIZE="-0.24344692473899995" NO="1" P_CHI2="0.09684341565397836" P_Z="0.002373228220809564" STUDIES="3" TAU2="0.0" TOTAL_1="37" TOTAL_2="34" WEIGHT="100.0" Z="3.0390533514751414">
<NAME>primary ED</NAME>
<DICH_DATA CI_END="1.1016071659441518" CI_START="0.5009378585704063" EFFECT_SIZE="0.7428571428571429" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="15" LOG_CI_END="0.04202675233953586" LOG_CI_START="-0.3002161450984511" LOG_EFFECT_SIZE="-0.12909469637945764" ORDER="2611" O_E="0.0" SE="0.20103517208473848" STUDY_ID="STD-Ansari-1976" TOTAL_1="21" TOTAL_2="18" VAR="0.04041514041514041" WEIGHT="52.69761606022585"/>
<DICH_DATA CI_END="1.2979384535601666" CI_START="0.3930880391386773" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.11325409931109688" LOG_CI_START="-0.405510170667573" LOG_EFFECT_SIZE="-0.146128035678238" ORDER="2612" O_E="0.0" SE="0.304724700110022" STUDY_ID="STD-Kockott-1975" TOTAL_1="8" TOTAL_2="8" VAR="0.09285714285714286" WEIGHT="22.835633626097867"/>
<DICH_DATA CI_END="1.0014627490096395" CI_START="0.004437952833332663" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="6.347996601127133E-4" LOG_CI_START="-2.352817317771475" LOG_EFFECT_SIZE="-1.1760912590556813" ORDER="2613" O_E="0.0" SE="1.3824294235551813" STUDY_ID="STD-Munjack-1984" TOTAL_1="8" TOTAL_2="8" VAR="1.911111111111111" WEIGHT="24.466750313676286"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.6913468526683952" CI_END="0.4298988363693509" CI_START="0.038935059500334455" DF="1.0" EFFECT_SIZE="0.1293759512937595" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="11" I2="62.8438824595006" ID="CMP-001.03.02" LOG_CI_END="-0.366633730409985" LOG_CI_START="-1.4096591572809913" LOG_EFFECT_SIZE="-0.888146443845488" NO="2" P_CHI2="0.10089456341460112" P_Z="8.442708170393716E-4" STUDIES="2" TAU2="0.0" TOTAL_1="18" TOTAL_2="11" WEIGHT="100.0" Z="3.3378573486104743">
<NAME>secondary ED</NAME>
<DICH_DATA CI_END="1.312332503184805" CI_START="0.08466688955844923" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.1180438853468899" LOG_CI_START="-1.072286394786215" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="2614" O_E="0.0" SE="0.699205898780101" STUDY_ID="STD-Kilmann-1987" TOTAL_1="4" TOTAL_2="4" VAR="0.4888888888888889" WEIGHT="31.506849315068493"/>
<DICH_DATA CI_END="0.5457618720039037" CI_START="0.0023163903447897044" EFFECT_SIZE="0.035555555555555556" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="-0.2629968082716766" LOG_CI_START="-2.6351882539671614" LOG_EFFECT_SIZE="-1.449092531119419" ORDER="2615" O_E="0.0" SE="1.3934369977385652" STUDY_ID="STD-Price-1981" TOTAL_1="14" TOTAL_2="7" VAR="1.9416666666666664" WEIGHT="68.4931506849315"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="15.278242080697314" CI_END="0.9770659764891516" CI_START="0.16509333223901854" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4016305240839702" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="40" I2="73.81897747873991" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="-0.010076109507689565" LOG_CI_START="-0.7822704665935182" LOG_EFFECT_SIZE="-0.39617328805060387" METHOD="MH" NO="4" P_CHI2="0.0041575992797237005" P_Q="0.0" P_Z="0.044313434502991036" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.5752275307561009" TOTALS="SUB" TOTAL_1="55" TOTAL_2="45" WEIGHT="200.0" Z="2.0111138318761133">
<NAME>persistence of erectile dysfunction - according to the group mean age of the patients</NAME>
<GROUP_LABEL_1>group therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>waiting list</GROUP_LABEL_2>
<GRAPH_LABEL_1>group therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>waiting list</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2979384535601666" CI_START="0.3930880391386773" DF="0.0" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" I2="0.0" ID="CMP-001.04.01" LOG_CI_END="0.11325409931109688" LOG_CI_START="-0.405510170667573" LOG_EFFECT_SIZE="-0.146128035678238" NO="1" P_CHI2="1.0" P_Z="0.26951320633089026" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="1.1041843227665114">
<NAME>from 30 to 39 years old</NAME>
<DICH_DATA CI_END="1.2979384535601666" CI_START="0.3930880391386773" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.11325409931109688" LOG_CI_START="-0.405510170667573" LOG_EFFECT_SIZE="-0.146128035678238" ORDER="2616" O_E="0.0" SE="0.304724700110022" STUDY_ID="STD-Kockott-1975" TOTAL_1="8" TOTAL_2="8" VAR="0.09285714285714286" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="15.763828407093092" CI_END="1.2079465440146158" CI_START="0.03766644087875837" DF="3.0" EFFECT_SIZE="0.21330505639770242" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="33" I2="80.96908997911878" ID="CMP-001.04.02" LOG_CI_END="0.08204771561528079" LOG_CI_START="-1.4240454145655317" LOG_EFFECT_SIZE="-0.6709988494751256" NO="2" P_CHI2="0.0012676759971973484" P_Z="0.08073845912492103" STUDIES="4" TAU2="2.256686254819376" TOTAL_1="47" TOTAL_2="37" WEIGHT="100.0" Z="1.74641733938614">
<NAME>45 years and older</NAME>
<DICH_DATA CI_END="1.1016071659441518" CI_START="0.5009378585704063" EFFECT_SIZE="0.7428571428571429" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="15" LOG_CI_END="0.04202675233953586" LOG_CI_START="-0.3002161450984511" LOG_EFFECT_SIZE="-0.12909469637945764" ORDER="2617" O_E="0.0" SE="0.20103517208473848" STUDY_ID="STD-Ansari-1976" TOTAL_1="21" TOTAL_2="18" VAR="0.04041514041514041" WEIGHT="48.29139054529437"/>
<DICH_DATA CI_END="1.312332503184805" CI_START="0.08466688955844923" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.1180438853468899" LOG_CI_START="-1.072286394786215" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="2618" O_E="0.0" SE="0.699205898780101" STUDY_ID="STD-Kilmann-1987" TOTAL_1="4" TOTAL_2="4" VAR="0.4888888888888889" WEIGHT="27.938898527472443"/>
<DICH_DATA CI_END="1.0014627490096395" CI_START="0.004437952833332663" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="6.347996601127133E-4" LOG_CI_START="-2.352817317771475" LOG_EFFECT_SIZE="-1.1760912590556813" ORDER="2619" O_E="0.0" SE="1.3824294235551813" STUDY_ID="STD-Munjack-1984" TOTAL_1="8" TOTAL_2="8" VAR="1.911111111111111" WEIGHT="11.957438206225834"/>
<DICH_DATA CI_END="0.5457618720039037" CI_START="0.0023163903447897044" EFFECT_SIZE="0.035555555555555556" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="-0.2629968082716766" LOG_CI_START="-2.6351882539671614" LOG_EFFECT_SIZE="-1.449092531119419" ORDER="2620" O_E="0.0" SE="1.3934369977385652" STUDY_ID="STD-Price-1981" TOTAL_1="14" TOTAL_2="7" VAR="1.9416666666666664" WEIGHT="11.812272721007353"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="15.278242080697312" CI_END="0.6126583482466363" CI_START="0.30258568664598406" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4305596903840429" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="40" I2="73.8189774787399" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="-0.21278164429923704" LOG_CI_START="-0.5191516194644795" LOG_EFFECT_SIZE="-0.3659666318818583" METHOD="MH" NO="5" P_CHI2="0.004157599279723145" P_Q="0.0" P_Z="2.834629766815951E-6" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="55" TOTAL_2="45" WEIGHT="200.0" Z="4.682452434478937">
<NAME>persistence of erectile dysfunction - according to partnership</NAME>
<GROUP_LABEL_1>group therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>waiting list</GROUP_LABEL_2>
<GRAPH_LABEL_1>group therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>waiting list</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="6.109512832239311" CI_END="0.7685623167567364" CI_START="0.3800864781554081" DF="3.0" EFFECT_SIZE="0.5404814004376368" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="33" I2="50.89624848368779" ID="CMP-001.05.01" LOG_CI_END="-0.1143209131657282" LOG_CI_START="-0.4201175804546407" LOG_EFFECT_SIZE="-0.26721924681018444" NO="1" P_CHI2="0.10640212835626983" P_Z="6.138631353040721E-4" STUDIES="4" TAU2="0.0" TOTAL_1="41" TOTAL_2="38" WEIGHT="100.0" Z="3.4254140463150224">
<NAME>male with fixed partnership</NAME>
<DICH_DATA CI_END="1.1016071659441518" CI_START="0.5009378585704063" EFFECT_SIZE="0.7428571428571429" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="15" LOG_CI_END="0.04202675233953586" LOG_CI_START="-0.3002161450984511" LOG_EFFECT_SIZE="-0.12909469637945764" ORDER="2621" O_E="0.0" SE="0.20103517208473848" STUDY_ID="STD-Ansari-1976" TOTAL_1="21" TOTAL_2="18" VAR="0.04041514041514041" WEIGHT="45.951859956236326"/>
<DICH_DATA CI_END="1.312332503184805" CI_START="0.08466688955844923" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.1180438853468899" LOG_CI_START="-1.072286394786215" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="2622" O_E="0.0" SE="0.699205898780101" STUDY_ID="STD-Kilmann-1987" TOTAL_1="4" TOTAL_2="4" VAR="0.4888888888888889" WEIGHT="12.800875273522976"/>
<DICH_DATA CI_END="1.2979384535601666" CI_START="0.3930880391386773" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.11325409931109688" LOG_CI_START="-0.405510170667573" LOG_EFFECT_SIZE="-0.146128035678238" ORDER="2623" O_E="0.0" SE="0.304724700110022" STUDY_ID="STD-Kockott-1975" TOTAL_1="8" TOTAL_2="8" VAR="0.09285714285714286" WEIGHT="19.91247264770241"/>
<DICH_DATA CI_END="1.0014627490096395" CI_START="0.004437952833332663" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="6.347996601127133E-4" LOG_CI_START="-2.352817317771475" LOG_EFFECT_SIZE="-1.1760912590556813" ORDER="2624" O_E="0.0" SE="1.3824294235551813" STUDY_ID="STD-Munjack-1984" TOTAL_1="8" TOTAL_2="8" VAR="1.911111111111111" WEIGHT="21.334792122538293"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.5457618720039039" CI_START="0.002316390344789702" DF="0.0" EFFECT_SIZE="0.035555555555555556" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" I2="0.0" ID="CMP-001.05.02" LOG_CI_END="-0.2629968082716765" LOG_CI_START="-2.635188253967162" LOG_EFFECT_SIZE="-1.449092531119419" NO="2" P_CHI2="1.0" P_Z="0.016640634455358162" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="7" WEIGHT="99.99999999999999" Z="2.3945530841650604">
<NAME>male without fixed partnership</NAME>
<DICH_DATA CI_END="0.5457618720039037" CI_START="0.0023163903447897044" EFFECT_SIZE="0.035555555555555556" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="-0.2629968082716766" LOG_CI_START="-2.6351882539671614" LOG_EFFECT_SIZE="-1.449092531119419" ORDER="2625" O_E="0.0" SE="1.3934369977385652" STUDY_ID="STD-Price-1981" TOTAL_1="14" TOTAL_2="7" VAR="1.9416666666666664" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>PSYCHOEDUCATIONAL INTERVENTION VERSUS NO TREATMENT</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>ASKAS Knowledge Scale (low is better)</NAME>
<GROUP_LABEL_1>workshop</GROUP_LABEL_1>
<GROUP_LABEL_2>no treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>workshop</GRAPH_LABEL_1>
<GRAPH_LABEL_2>no-treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>post-treatment</NAME>
<CONT_DATA CI_END="3.4396465143051085" CI_START="-14.739646514305106" EFFECT_SIZE="-5.649999999999999" ESTIMABLE="YES" MEAN_1="51.65" MEAN_2="57.3" ORDER="2626" SD_1="7.67" SD_2="12.5" SE="4.637659970286739" STUDY_ID="STD-Goldman-1990" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.02" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>ASKAS Attitude Scale (low is better)</NAME>
<GROUP_LABEL_1>Workshop</GROUP_LABEL_1>
<GROUP_LABEL_2>no treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Workshop</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no-treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>post-treatment</NAME>
<CONT_DATA CI_END="24.677245659738304" CI_START="-23.2772456597383" EFFECT_SIZE="0.7000000000000028" ESTIMABLE="YES" MEAN_1="61.7" MEAN_2="61.0" ORDER="2627" SD_1="28.38" SD_2="26.29" SE="12.233513395586732" STUDY_ID="STD-Goldman-1990" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.03" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Sexual Interaction Inventory: mean pleasure (high is better)</NAME>
<GROUP_LABEL_1>Waiting list</GROUP_LABEL_1>
<GROUP_LABEL_2>Workshop</GROUP_LABEL_2>
<GRAPH_LABEL_1>waiting list</GRAPH_LABEL_1>
<GRAPH_LABEL_2>workshop</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.03.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>post-treatment</NAME>
<CONT_DATA CI_END="0.7185947666885928" CI_START="-0.31859476668859243" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="5.26" MEAN_2="5.06" ORDER="2628" SD_1="0.35" SD_2="0.76" SE="0.2645940286552212" STUDY_ID="STD-Goldman-1990" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" NO="3">
<NAME>GROUP INTERVENTIONS: SYSTEMATIC DESENSITIZATION VERSUS ROUTINE GROUP THERAPY</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="5" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="8" TOTAL_2="8" WEIGHT="0.0" Z="0.0">
<NAME>persistence of erectile dysfunction</NAME>
<GROUP_LABEL_1>Systematic Dens</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours RG</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="5" EVENTS_2="5" I2="0.0" ID="CMP-003.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="0.0" Z="0.0">
<NAME>post-treatment</NAME>
<DICH_DATA CI_END="2.1363329557898925" CI_START="0.46809182870572613" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.32966894011371894" LOG_CI_START="-0.329668940113719" LOG_EFFECT_SIZE="0.0" ORDER="2629" O_E="0.0" SE="0.3872983346207417" STUDY_ID="STD-Kockott-1975" TOTAL_1="8" TOTAL_2="8" VAR="0.15000000000000002" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" NO="4">
<NAME>GROUP THERAPY VERSUS SILDENAFIL CITRATE</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="14" TOTAL_2="14" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>International Index of Erectile Dysfunction (high is better)</NAME>
<GROUP_LABEL_1>group therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>sildenafil</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sildenafil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours GT</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="6" WEIGHT="0.0" Z="0.0">
<NAME>post-treatment</NAME>
<CONT_DATA CI_END="22.169969123455534" CI_START="2.6300308765444633" EFFECT_SIZE="12.399999999999999" ESTIMABLE="YES" MEAN_1="61.23" MEAN_2="48.83" ORDER="2630" SD_1="9.23" SD_2="9.23" SE="4.984769720525379" STUDY_ID="STD-Melnik-2005" TOTAL_1="8" TOTAL_2="6" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.01.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="6" TOTAL_2="8" WEIGHT="0.0" Z="0.0">
<NAME>3 months follow up</NAME>
<CONT_DATA CI_END="-2.310324363870248" CI_START="-17.029675636129756" EFFECT_SIZE="-9.670000000000002" ESTIMABLE="YES" MEAN_1="52.83" MEAN_2="62.5" ORDER="2631" SD_1="7.91" SD_2="5.42" SE="3.7550055481539126" STUDY_ID="STD-Melnik-2005" TOTAL_1="6" TOTAL_2="8" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>Dropouts</NAME>
<GROUP_LABEL_1>Group Therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>Sildenafil</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Group</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Sildenafil</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.7719488038743916" CI_START="0.05073145644084281" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4427852048718864" LOG_CI_START="-1.2947226694164486" LOG_EFFECT_SIZE="-0.42596873227228116" ORDER="2632" O_E="0.0" SE="1.0206207261596576" STUDY_ID="STD-Melnik-2005" TOTAL_1="10" TOTAL_2="10" VAR="1.0416666666666667" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" NO="5">
<NAME>GROUP THERAPY PLUS SILDENAFIL VERSUS SILDENAFIL</NAME>
<DICH_OUTCOME CHI2="0.10839603364264454" CI_END="0.8823885121861441" CI_START="0.23685837606934015" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.45716639209225696" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="-0.05434015460984576" LOG_CI_START="-0.6255112526232793" LOG_EFFECT_SIZE="-0.3399257036165626" METHOD="MH" NO="1" P_CHI2="0.7419777068659914" P_Q="0.0" P_Z="0.019653466218482466" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="38" TOTAL_2="33" WEIGHT="100.0" Z="2.332898631688923">
<NAME>Persistence of erectile dysfunction</NAME>
<GROUP_LABEL_1>psycho+ sildenafil</GROUP_LABEL_1>
<GROUP_LABEL_2>sildenafil</GROUP_LABEL_2>
<GRAPH_LABEL_1>psycho + sildenafil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>sildenafil</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.0337534780364321" CI_START="0.22718382670112802" EFFECT_SIZE="0.4846153846153846" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="13" LOG_CI_END="0.014416983735441612" LOG_CI_START="-0.6436225894419517" LOG_EFFECT_SIZE="-0.31460280285325504" ORDER="2633" O_E="0.0" SE="0.386535702632822" STUDY_ID="STD-Banner-2000" TOTAL_1="30" TOTAL_2="27" VAR="0.14940984940984942" WEIGHT="74.95881383855026"/>
<DICH_DATA CI_END="1.4135052851038035" CI_START="0.09948671680394386" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.15029743665795936" LOG_CI_START="-1.0022349012025216" LOG_EFFECT_SIZE="-0.42596873227228116" ORDER="2634" O_E="0.0" SE="0.6770032003863301" STUDY_ID="STD-Melnik-2005" TOTAL_1="8" TOTAL_2="6" VAR="0.45833333333333337" WEIGHT="25.04118616144975"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.948125739867592" CI_END="0.9267839255995162" CI_START="0.08808164536131562" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.2857142857142857" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-005.02" LOG_CI_END="-0.03302150734210746" LOG_CI_START="-1.0551145813584437" LOG_EFFECT_SIZE="-0.5440680443502757" METHOD="MH" NO="2" P_CHI2="0.3301970073242043" P_Q="0.0" P_Z="0.03692358716372604" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="40" TOTAL_2="37" WEIGHT="100.0" Z="2.0866079600274006">
<NAME>Dropouts</NAME>
<GROUP_LABEL_1>GT plus Sildenafil</GROUP_LABEL_1>
<GROUP_LABEL_2>Sildenafil</GROUP_LABEL_2>
<GRAPH_LABEL_1>GT + sildenafil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>sildenafil</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1677093552999085" CI_START="0.019268493395106195" EFFECT_SIZE="0.15" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.06733475964539587" LOG_CI_START="-1.7151522415340335" LOG_EFFECT_SIZE="-0.8239087409443188" ORDER="2635" O_E="0.0" SE="1.0470416879457554" STUDY_ID="STD-Banner-2000" TOTAL_1="30" TOTAL_2="27" VAR="1.0962962962962963" WEIGHT="61.22448979591837"/>
<DICH_DATA CI_END="2.13913386929134" CI_START="0.1168697310574681" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.3302379640363697" LOG_CI_START="-0.932297955364332" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="2636" O_E="0.0" SE="0.7416198487095663" STUDY_ID="STD-Melnik-2005" TOTAL_1="10" TOTAL_2="10" VAR="0.55" WEIGHT="38.775510204081634"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" NO="6">
<NAME>GROUP THERAPY VERSUS OXAZEPAM</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="21" TOTAL_2="16" WEIGHT="0.0" Z="0.0">
<NAME>persistence of erectile dysfunction</NAME>
<GROUP_LABEL_1>psychotherapy</GROUP_LABEL_1>
<GROUP_LABEL_2>oxazepam</GROUP_LABEL_2>
<GRAPH_LABEL_1>psychotherapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>oxazepam</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.9233380182552329" CI_START="0.3018184326953381" EFFECT_SIZE="0.7619047619047619" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.2840556163043105" LOG_CI_START="-0.5202542404602994" LOG_EFFECT_SIZE="-0.11809931207799451" ORDER="2637" O_E="0.0" SE="0.472455591261534" STUDY_ID="STD-Ansari-1976" TOTAL_1="21" TOTAL_2="16" VAR="0.2232142857142857" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" NO="7">
<NAME>SEX THERAPY VERSUS INTRACAVERNOUSAL INJECTION</NAME>
<DICH_OUTCOME CHI2="0.038086839513923235" CI_END="2.3408530239951215" CI_START="0.8333411797851618" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.396685082872928" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="16" I2="0.0" I2_Q="0.0" ID="CMP-007.01" LOG_CI_END="0.369374146344324" LOG_CI_START="-0.07917715686199824" LOG_EFFECT_SIZE="0.14509849474116285" METHOD="MH" NO="1" P_CHI2="0.8452689484835878" P_Q="0.0" P_Z="0.2047879481848498" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="53" TOTAL_2="54" WEIGHT="100.0" Z="1.268028080047033">
<NAME>Dropouts</NAME>
<GROUP_LABEL_1>ST</GROUP_LABEL_1>
<GROUP_LABEL_2>ICI</GROUP_LABEL_2>
<GRAPH_LABEL_1>ST</GRAPH_LABEL_1>
<GRAPH_LABEL_2>ICI</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.5875999972835135" CI_START="0.6870373240238464" DF="0.0" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="9" I2="0.0" ID="CMP-007.01.01" LOG_CI_END="0.41289714201252437" LOG_CI_START="-0.16301966879592453" LOG_EFFECT_SIZE="0.12493873660829992" NO="1" P_CHI2="1.0" P_Z="0.3951112446704488" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="25" WEIGHT="56.68508287292818" Z="0.8503847063691633">
<NAME>ST alone</NAME>
<DICH_DATA CI_END="2.587599997283513" CI_START="0.6870373240238465" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="9" LOG_CI_END="0.41289714201252425" LOG_CI_START="-0.16301966879592444" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="2638" O_E="0.0" SE="0.33829638550307395" STUDY_ID="STD-Baum-2000" TOTAL_1="25" TOTAL_2="25" VAR="0.1144444444444444" WEIGHT="56.68508287292818"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.3406924702655876" CI_START="0.6553108443286019" DF="0.0" EFFECT_SIZE="1.4795918367346939" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="7" I2="0.0" ID="CMP-007.01.02" LOG_CI_END="0.5238364982020655" LOG_CI_START="-0.18355264511710542" LOG_EFFECT_SIZE="0.17014192654248003" NO="2" P_CHI2="1.0" P_Z="0.34577048590252535" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="29" WEIGHT="43.31491712707182" Z="0.9428248975346777">
<NAME>ST associated to ICI</NAME>
<DICH_DATA CI_END="3.340692470265587" CI_START="0.6553108443286019" EFFECT_SIZE="1.4795918367346939" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="7" LOG_CI_END="0.5238364982020653" LOG_CI_START="-0.18355264511710542" LOG_EFFECT_SIZE="0.17014192654248003" ORDER="2639" O_E="0.0" SE="0.415523884418414" STUDY_ID="STD-Van-Der-Windt-2002" TOTAL_1="28" TOTAL_2="29" VAR="0.17266009852216746" WEIGHT="43.31491712707182"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.475892864658974" CI_END="1.9687251973274538" CI_START="0.6241767025520196" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1085271317829457" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="14" I2="59.6105302344034" I2_Q="0.0" ID="CMP-007.02" LOG_CI_END="0.294185099777904" LOG_CI_START="-0.20469244544627835" LOG_EFFECT_SIZE="0.04474632716581284" METHOD="MH" NO="2" P_CHI2="0.1156040348933931" P_Q="0.0" P_Z="0.7251427245284339" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="44" TOTAL_2="42" WEIGHT="100.0" Z="0.35159405559546203">
<NAME>Persistence of erectile dysfunction</NAME>
<GROUP_LABEL_1>ST</GROUP_LABEL_1>
<GROUP_LABEL_2>ICI</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ST</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours ICI</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.6680460371964418" CI_START="0.14247583382017398" DF="0.0" EFFECT_SIZE="0.4875" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" I2="0.0" ID="CMP-007.02.01" LOG_CI_END="0.22220803276722745" LOG_CI_START="-0.8462587926981162" LOG_EFFECT_SIZE="-0.3120253799654444" NO="1" P_CHI2="1.0" P_Z="0.2523167792960116" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="13" WEIGHT="38.42264914054601" Z="1.1447402809691314">
<NAME>ST alone</NAME>
<DICH_DATA CI_END="1.6680460371964418" CI_START="0.14247583382017398" EFFECT_SIZE="0.4875" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.22220803276722745" LOG_CI_START="-0.8462587926981162" LOG_EFFECT_SIZE="-0.3120253799654444" ORDER="2640" O_E="0.0" SE="0.6276227022744288" STUDY_ID="STD-Baum-2000" TOTAL_1="16" TOTAL_2="13" VAR="0.3939102564102564" WEIGHT="38.42264914054601"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.9318132123949425" CI_START="0.7633879865445194" DF="0.0" EFFECT_SIZE="1.496031746031746" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="9" I2="0.0" ID="CMP-007.02.02" LOG_CI_END="0.46713629768456166" LOG_CI_START="-0.11725467883606411" LOG_EFFECT_SIZE="0.17494080942424875" NO="2" P_CHI2="1.0" P_Z="0.24061419596113298" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="29" WEIGHT="61.57735085945399" Z="1.1734530465862223">
<NAME>ST associated to ICI</NAME>
<DICH_DATA CI_END="2.9318132123949425" CI_START="0.7633879865445194" EFFECT_SIZE="1.496031746031746" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="9" LOG_CI_END="0.46713629768456166" LOG_CI_START="-0.11725467883606411" LOG_EFFECT_SIZE="0.17494080942424875" ORDER="2641" O_E="0.0" SE="0.34327415239020354" STUDY_ID="STD-Van-Der-Windt-2002" TOTAL_1="28" TOTAL_2="29" VAR="0.11783714369921268" WEIGHT="61.57735085945399"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-007.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="16" TOTAL_2="13" WEIGHT="0.0" Z="0.0">
<NAME>Not confident in performance</NAME>
<GROUP_LABEL_1>ST</GROUP_LABEL_1>
<GROUP_LABEL_2>ICI</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ST</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours ICI</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="3" I2="0.0" ID="CMP-007.03.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="13" WEIGHT="0.0" Z="0.0">
<NAME>6 months follow up</NAME>
<DICH_DATA CI_END="3.998422410543096" CI_START="0.29351854071658784" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.601888672943021" LOG_CI_START="-0.5323644604245972" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="2642" O_E="0.0" SE="0.6662659051837009" STUDY_ID="STD-Baum-2000" TOTAL_1="16" TOTAL_2="13" VAR="0.44391025641025633" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-007.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="16" TOTAL_2="13" WEIGHT="0.0" Z="0.0">
<NAME>not extremely satisfied with treatment</NAME>
<GROUP_LABEL_1>ST</GROUP_LABEL_1>
<GROUP_LABEL_2>ICI</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ST</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours ICI</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.6360482984594853" CI_START="0.25043404947693765" EFFECT_SIZE="0.8125" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.4209533632672969" LOG_CI_START="-0.6013066239654729" LOG_EFFECT_SIZE="-0.09017663034908802" ORDER="2643" O_E="0.0" SE="0.6004805767690767" STUDY_ID="STD-Baum-2000" TOTAL_1="16" TOTAL_2="13" VAR="0.3605769230769231" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="5" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-007.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="28" TOTAL_2="29" WEIGHT="0.0" Z="0.0">
<NAME>Partners reporting the treatment to be disturbing</NAME>
<GROUP_LABEL_1>ICI with ST</GROUP_LABEL_1>
<GROUP_LABEL_2>ICI without ST</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ICI with ST</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Fav. ICI without ST</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="5" EVENTS_2="4" I2="0.0" ID="CMP-007.05.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="29" WEIGHT="0.0" Z="0.0">
<NAME>ST associated to ICI</NAME>
<DICH_DATA CI_END="4.332412404922553" CI_START="0.3868745564588012" EFFECT_SIZE="1.2946428571428572" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6367297906719668" LOG_CI_START="-0.4124298315423801" LOG_EFFECT_SIZE="0.1121499795647933" ORDER="2644" O_E="0.0" SE="0.6162815555125958" STUDY_ID="STD-Van-Der-Windt-2002" TOTAL_1="28" TOTAL_2="29" VAR="0.37980295566502464" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" NO="8">
<NAME>SEX THERAPY VERSUS VACCUM DEVICES</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-008.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="50" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>Response to treatment as assessed by therapist</NAME>
<GROUP_LABEL_1>sex therapy + VCD</GROUP_LABEL_1>
<GROUP_LABEL_2>sex therapy</GROUP_LABEL_2>
<GRAPH_LABEL_1>ST + VCD</GRAPH_LABEL_1>
<GRAPH_LABEL_2>ST</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="8" I2="0.0" ID="CMP-008.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>post-treatment (persistence of erectile dysfunction)</NAME>
<DICH_DATA CI_END="1.1388781624083715" CI_START="0.14048912805707856" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.05647726558570389" LOG_CI_START="-0.8523572829297791" LOG_EFFECT_SIZE="-0.3979400086720376" ORDER="2645" O_E="0.0" SE="0.5338539126015656" STUDY_ID="STD-Wylie-2003" TOTAL_1="25" TOTAL_2="20" VAR="0.28500000000000003" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-008.01.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>six weeks ( persistence of erectile dysfunction)</NAME>
<DICH_DATA CI_END="6.273531804529307" CI_START="0.011554130808464149" EFFECT_SIZE="0.2692307692307692" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.7975121040498601" LOG_CI_START="-1.937262719962982" LOG_EFFECT_SIZE="-0.5698753079565612" ORDER="2646" O_E="0.0" SE="1.60642026897885" STUDY_ID="STD-Wylie-2003" TOTAL_1="25" TOTAL_2="20" VAR="2.5805860805860807" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES/>
<EXTENSIONS/>
</COCHRANE_REVIEW>